Cemtrex
CETX
#10409
Rank
S$16.53 M
Marketcap
S$1.64
Share price
5.74%
Change (1 day)
3.89%
Change (1 year)

Cemtrex - 10-Q quarterly report FY2026 Q1


Text size:
false--09-30Q12026000143506400014350642025-10-012025-12-3100014350642026-02-1300014350642025-12-3100014350642025-09-300001435064us-gaap:NonrelatedPartyMember2025-12-310001435064us-gaap:NonrelatedPartyMember2025-09-300001435064us-gaap:RelatedPartyMember2025-12-310001435064us-gaap:RelatedPartyMember2025-09-300001435064us-gaap:PreferredStockMember2025-12-310001435064us-gaap:PreferredStockMember2025-09-300001435064us-gaap:SeriesCPreferredStockMember2025-12-310001435064us-gaap:SeriesCPreferredStockMember2025-09-300001435064CETX:SeriesOnePreferredStockMember2025-12-310001435064CETX:SeriesOnePreferredStockMember2025-09-3000014350642024-10-012024-12-310001435064us-gaap:PreferredStockMemberCETX:SeriesOnePreferredStockMember2025-09-300001435064us-gaap:PreferredStockMemberus-gaap:SeriesCPreferredStockMember2025-09-300001435064us-gaap:CommonStockMember2025-09-300001435064us-gaap:AdditionalPaidInCapitalMember2025-09-300001435064us-gaap:RetainedEarningsMember2025-09-300001435064us-gaap:TreasuryStockPreferredMember2025-09-300001435064us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-09-300001435064us-gaap:PreferredStockMemberCETX:SeriesOnePreferredStockMember2024-09-300001435064us-gaap:PreferredStockMemberus-gaap:SeriesCPreferredStockMember2024-09-300001435064us-gaap:CommonStockMember2024-09-300001435064us-gaap:AdditionalPaidInCapitalMember2024-09-300001435064us-gaap:RetainedEarningsMember2024-09-300001435064us-gaap:TreasuryStockPreferredMember2024-09-300001435064us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-09-3000014350642024-09-300001435064CETX:MinorityInterestMember2024-09-300001435064us-gaap:PreferredStockMemberCETX:SeriesOnePreferredStockMember2025-10-012025-12-310001435064us-gaap:PreferredStockMemberus-gaap:SeriesCPreferredStockMember2025-10-012025-12-310001435064us-gaap:CommonStockMember2025-10-012025-12-310001435064us-gaap:AdditionalPaidInCapitalMember2025-10-012025-12-310001435064us-gaap:RetainedEarningsMember2025-10-012025-12-310001435064us-gaap:TreasuryStockPreferredMember2025-10-012025-12-310001435064us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-10-012025-12-310001435064us-gaap:PreferredStockMemberCETX:SeriesOnePreferredStockMember2024-10-012024-12-310001435064us-gaap:PreferredStockMemberus-gaap:SeriesCPreferredStockMember2024-10-012024-12-310001435064us-gaap:CommonStockMember2024-10-012024-12-310001435064us-gaap:AdditionalPaidInCapitalMember2024-10-012024-12-310001435064us-gaap:RetainedEarningsMember2024-10-012024-12-310001435064us-gaap:TreasuryStockPreferredMember2024-10-012024-12-310001435064us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-10-012024-12-310001435064CETX:MinorityInterestMember2024-10-012024-12-310001435064us-gaap:PreferredStockMemberCETX:SeriesOnePreferredStockMember2025-12-310001435064us-gaap:PreferredStockMemberus-gaap:SeriesCPreferredStockMember2025-12-310001435064us-gaap:CommonStockMember2025-12-310001435064us-gaap:AdditionalPaidInCapitalMember2025-12-310001435064us-gaap:RetainedEarningsMember2025-12-310001435064us-gaap:TreasuryStockPreferredMember2025-12-310001435064us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-12-310001435064us-gaap:PreferredStockMemberCETX:SeriesOnePreferredStockMember2024-12-310001435064us-gaap:PreferredStockMemberus-gaap:SeriesCPreferredStockMember2024-12-310001435064us-gaap:CommonStockMember2024-12-310001435064us-gaap:AdditionalPaidInCapitalMember2024-12-310001435064us-gaap:RetainedEarningsMember2024-12-310001435064us-gaap:TreasuryStockPreferredMember2024-12-310001435064us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-12-3100014350642024-12-310001435064CETX:MinorityInterestMember2024-12-310001435064us-gaap:CommonStockMember2024-10-022024-10-020001435064us-gaap:CommonStockMember2024-11-262024-11-260001435064us-gaap:CommonStockMember2025-09-292025-09-290001435064us-gaap:SubsequentEventMemberCETX:SharePurchaseAgreementMember2026-01-082026-01-080001435064us-gaap:SubsequentEventMemberCETX:RichlandIndustriesLLCMember2026-02-052026-02-050001435064us-gaap:SubsequentEventMemberCETX:RichlandIndustriesLLCMember2026-02-050001435064CETX:FultonBankMortgagePayableMemberus-gaap:SubsequentEventMember2026-02-050001435064CETX:FultonBankMortgagePayableMemberus-gaap:SubsequentEventMember2026-02-052026-02-0500014350642024-10-012025-09-3000014350642023-10-012024-09-300001435064srt:ScenarioPreviouslyReportedMember2024-10-012024-12-310001435064srt:RevisionOfPriorPeriodReclassificationAdjustmentMember2024-10-012024-12-310001435064CETX:CorrectionMember2024-10-012024-12-310001435064srt:ScenarioPreviouslyReportedMember2025-10-012025-12-310001435064srt:RevisionOfPriorPeriodReclassificationAdjustmentMember2025-10-012025-12-310001435064CETX:CorrectionMember2025-10-012025-12-310001435064us-gaap:TransferredOverTimeMember2025-12-310001435064us-gaap:TransferredOverTimeMember2024-12-310001435064us-gaap:TransferredAtPointInTimeMember2025-12-310001435064us-gaap:TransferredAtPointInTimeMember2024-12-310001435064us-gaap:EmployeeStockOptionMember2025-10-012025-12-310001435064us-gaap:EmployeeStockOptionMember2024-10-012024-12-310001435064us-gaap:WarrantMember2025-10-012025-12-310001435064us-gaap:WarrantMember2024-10-012024-12-310001435064CETX:SecurityMember2025-10-012025-12-310001435064CETX:IndustrialServicesMember2025-10-012025-12-310001435064us-gaap:CorporateMember2025-10-012025-12-310001435064CETX:SecurityMember2024-10-012024-12-310001435064CETX:IndustrialServicesMember2024-10-012024-12-310001435064us-gaap:CorporateMember2024-10-012024-12-310001435064CETX:SecurityMember2025-12-310001435064CETX:SecurityMember2025-09-300001435064CETX:IndustrialServicesMember2025-12-310001435064CETX:IndustrialServicesMember2025-09-300001435064us-gaap:CorporateMember2025-12-310001435064us-gaap:CorporateMember2025-09-300001435064CETX:BeneconGroupBondMember2025-12-310001435064CETX:BeneconGroupBondMember2025-09-300001435064CETX:HeiseyEscrowBondMember2025-12-310001435064CETX:HeiseyEscrowBondMember2025-09-300001435064CETX:BondEscrowMember2025-12-310001435064CETX:BondEscrowMember2025-09-300001435064CETX:DepositGuaranteesBondMember2025-12-310001435064CETX:DepositGuaranteesBondMember2025-09-300001435064us-gaap:FairValueInputsLevel1MemberCETX:DigitalAssetsMember2025-12-310001435064us-gaap:FairValueInputsLevel2MemberCETX:DigitalAssetsMember2025-12-310001435064us-gaap:FairValueInputsLevel3MemberCETX:DigitalAssetsMember2025-12-310001435064CETX:DigitalAssetsMember2025-12-310001435064us-gaap:FairValueInputsLevel1MemberCETX:MarketableSecuritiesMember2025-12-310001435064us-gaap:FairValueInputsLevel2MemberCETX:MarketableSecuritiesMember2025-12-310001435064us-gaap:FairValueInputsLevel3MemberCETX:MarketableSecuritiesMember2025-12-310001435064CETX:MarketableSecuritiesMember2025-12-310001435064us-gaap:FairValueInputsLevel1MemberCETX:WarrantLiabilitiesMember2025-12-310001435064us-gaap:FairValueInputsLevel2MemberCETX:WarrantLiabilitiesMember2025-12-310001435064us-gaap:FairValueInputsLevel3MemberCETX:WarrantLiabilitiesMember2025-12-310001435064CETX:WarrantLiabilitiesMember2025-12-310001435064us-gaap:FairValueInputsLevel1MemberCETX:DigitalAssetsMember2025-09-300001435064us-gaap:FairValueInputsLevel2MemberCETX:DigitalAssetsMember2025-09-300001435064us-gaap:FairValueInputsLevel3MemberCETX:DigitalAssetsMember2025-09-300001435064CETX:DigitalAssetsMember2025-09-300001435064us-gaap:FairValueInputsLevel1MemberCETX:WarrantLiabilitiesMember2025-09-300001435064us-gaap:FairValueInputsLevel2MemberCETX:WarrantLiabilitiesMember2025-09-300001435064us-gaap:FairValueInputsLevel3MemberCETX:WarrantLiabilitiesMember2025-09-300001435064CETX:WarrantLiabilitiesMember2025-09-3000014350642025-07-292025-07-290001435064CETX:SeriesBWarrantsMemberus-gaap:MeasurementInputExpectedTermMember2025-12-310001435064CETX:SeriesBWarrantsMemberus-gaap:MeasurementInputExpectedTermMember2025-09-300001435064CETX:SeriesBWarrantsMemberus-gaap:MeasurementInputRiskFreeInterestRateMember2025-12-310001435064CETX:SeriesBWarrantsMemberus-gaap:MeasurementInputRiskFreeInterestRateMember2025-09-300001435064CETX:SeriesBWarrantsMemberus-gaap:MeasurementInputOptionVolatilityMember2025-12-310001435064CETX:SeriesBWarrantsMemberus-gaap:MeasurementInputOptionVolatilityMember2025-09-300001435064CETX:SeriesBWarrantsMemberus-gaap:MeasurementInputExpectedDividendRateMember2025-12-310001435064CETX:SeriesBWarrantsMemberus-gaap:MeasurementInputExpectedDividendRateMember2025-09-300001435064CETX:SeriesBWarrantsMemberus-gaap:MeasurementInputSharePriceMember2025-12-310001435064CETX:SeriesBWarrantsMemberus-gaap:MeasurementInputSharePriceMember2025-09-300001435064CETX:SeriesAWarrantsMember2024-09-300001435064CETX:SeriesBWarrantsMember2024-09-300001435064CETX:SeriesAWarrantsMember2024-10-012025-09-300001435064CETX:SeriesBWarrantsMember2024-10-012025-09-300001435064CETX:SeriesAWarrantsMember2025-09-300001435064CETX:SeriesBWarrantsMember2025-09-300001435064CETX:SeriesAWarrantsMember2025-10-012025-12-310001435064CETX:SeriesBWarrantsMember2025-10-012025-12-310001435064CETX:SeriesAWarrantsMember2025-12-310001435064CETX:SeriesBWarrantsMember2025-12-310001435064us-gaap:LandMember2025-12-310001435064us-gaap:LandMember2025-09-300001435064us-gaap:BuildingImprovementsMember2025-12-310001435064us-gaap:BuildingImprovementsMember2025-09-300001435064us-gaap:FurnitureAndFixturesMember2025-12-310001435064us-gaap:FurnitureAndFixturesMember2025-09-300001435064us-gaap:ComputerEquipmentMember2025-12-310001435064us-gaap:ComputerEquipmentMember2025-09-300001435064us-gaap:MachineryAndEquipmentMember2025-12-310001435064us-gaap:MachineryAndEquipmentMember2025-09-300001435064CETX:CostOfRevenueAndGeneralAndAdministrativeExpenseMember2025-10-012025-12-310001435064CETX:CostOfRevenueAndGeneralAndAdministrativeExpenseMember2024-10-012024-12-310001435064CETX:SecurityMember2024-09-300001435064CETX:IndustrialServicesMember2024-09-300001435064CETX:SecurityMember2024-10-012025-09-300001435064CETX:IndustrialServicesMember2024-10-012025-09-3000014350642022-01-1900014350642020-11-1300014350642023-07-1800014350642023-10-0500014350642024-10-1700014350642024-11-180001435064CETX:SaagarGovilMember2025-01-062025-01-060001435064CETX:SaagarGovilMemberCETX:FirstYearMember2025-01-012025-01-010001435064CETX:SaagarGovilMemberCETX:SecondYearMember2025-01-012025-01-010001435064CETX:CemtrexXRIncMember2025-12-310001435064CETX:CXRIncMember2025-12-310001435064us-gaap:ServiceMemberCETX:CemtrexTechnologiesPvtLtdMember2025-12-310001435064CETX:TradeReceivablesNetMember2025-09-300001435064CETX:ContractAssetsNetMember2025-09-300001435064CETX:RoyaltiesReceivableNetRelatedPartyMember2025-09-300001435064CETX:TradeReceivablesNetMember2025-10-012025-12-310001435064CETX:ContractAssetsNetMember2025-10-012025-12-310001435064CETX:RoyaltiesReceivableNetRelatedPartyMember2025-10-012025-12-310001435064CETX:TradeReceivablesNetMember2025-12-310001435064CETX:ContractAssetsNetMember2025-12-310001435064CETX:RoyaltiesReceivableNetRelatedPartyMember2025-12-310001435064CETX:ClovisMember2025-12-310001435064CETX:ClovisMember2025-10-012025-12-310001435064CETX:ClovisMember2024-10-012024-12-3100014350642023-10-052023-10-050001435064CETX:StreetervilleCapitalLLCMember2025-11-070001435064CETX:StreetervilleCapitalLLCMember2025-12-310001435064us-gaap:SubsequentEventMember2026-01-012026-01-010001435064CETX:StreetervilleCapitalLLCMember2025-11-072025-11-070001435064us-gaap:SubsequentEventMember2026-01-010001435064CETX:FultonBankOneMember2025-12-310001435064CETX:FultonBankOneMember2025-10-012025-12-310001435064CETX:FultonBankOneMember2025-09-300001435064CETX:FultonBankMortgagePayableMember2025-12-310001435064CETX:FultonBankMortgagePayableMember2025-10-012025-12-310001435064CETX:FultonBankMortgagePayableMember2025-09-300001435064CETX:FultonBankHEISEYOneMember2025-12-310001435064CETX:FultonBankHEISEYOneMember2025-10-012025-12-310001435064CETX:FultonBankHEISEYOneMember2025-09-300001435064CETX:FultonBankHEISEYTwoMember2025-12-310001435064CETX:FultonBankHEISEYTwoMember2025-10-012025-12-310001435064CETX:FultonBankHEISEYTwoMember2025-09-300001435064CETX:NotesPayableOneMember2025-12-310001435064CETX:NotesPayableOneMember2025-10-012025-12-310001435064CETX:NotesPayableOneMember2025-09-300001435064CETX:NotesPayableTwoMember2025-12-310001435064CETX:NotesPayableTwoMember2025-10-012025-12-310001435064CETX:NotesPayableTwoMember2025-09-300001435064CETX:NotesPayableThreeMember2025-12-310001435064CETX:NotesPayableThreeMember2025-10-012025-12-310001435064CETX:NotesPayableThreeMember2024-10-012025-09-300001435064CETX:NotesPayableOneMember2025-10-012025-12-310001435064CETX:NotesPayableOneMember2025-12-310001435064CETX:NotesPayableOneMember2025-09-300001435064CETX:NotesPayableTwoMember2025-10-012025-12-310001435064CETX:NotesPayableTwoMember2025-12-310001435064CETX:NotesPayableTwoMember2025-09-300001435064CETX:NotesPayableThreeMember2025-09-300001435064CETX:SeriesOnePreferredStockMember2025-10-012025-12-310001435064us-gaap:CommonStockMember2025-10-022025-10-020001435064us-gaap:CommonStockMember2025-11-262025-11-260001435064CETX:SeriesAWarrantsMember2025-10-012025-12-310001435064CETX:SeriesBWarrantsMember2025-10-012025-12-310001435064us-gaap:CommonStockMember2025-01-012025-12-310001435064CETX:SeriesAWarrantMember2025-10-130001435064CETX:SeriesBWarrantMember2025-10-1300014350642025-10-170001435064CETX:SeriesAWarrantMember2025-12-110001435064CETX:SeriesBWarrantMember2025-12-1100014350642025-12-110001435064CETX:SeriesAWarrantMember2025-12-300001435064CETX:SeriesBWarrantMember2025-12-3000014350642025-12-300001435064CETX:SecuritiesPurchaseAgreementMember2025-12-110001435064CETX:SecuritiesPurchaseAgreementMember2025-12-112025-12-110001435064CETX:SecuritiesPurchaseAgreementMemberus-gaap:CommonStockMember2025-12-112025-12-110001435064CETX:SecuritiesPurchaseAgreementMemberus-gaap:WarrantMember2025-12-110001435064CETX:SecuritiesPurchaseAgreementMemberus-gaap:CommonStockMember2025-12-110001435064CETX:SecuritiesPurchaseAgreementMember2025-12-230001435064CETX:SecuritiesPurchaseAgreementMember2025-12-232025-12-230001435064CETX:SecuritiesPurchaseAgreementMemberus-gaap:CommonStockMember2025-12-232025-12-230001435064CETX:SecuritiesPurchaseAgreementMemberus-gaap:WarrantMember2025-12-230001435064CETX:SecuritiesPurchaseAgreementMemberus-gaap:CommonStockMember2025-12-230001435064CETX:SecuritiesPurchaseAgreementMember2025-12-300001435064CETX:SecuritiesPurchaseAgreementMember2025-12-302025-12-300001435064CETX:SecuritiesPurchaseAgreementMemberus-gaap:CommonStockMember2025-12-302025-12-300001435064CETX:SecuritiesPurchaseAgreementMemberus-gaap:WarrantMember2025-12-300001435064CETX:SecuritiesPurchaseAgreementMemberus-gaap:CommonStockMember2025-12-300001435064CETX:FederalMember2025-12-310001435064us-gaap:StateAndLocalJurisdictionMember2025-12-310001435064us-gaap:ForeignCountryMember2025-12-310001435064us-gaap:SubsequentEventMemberCETX:SecuritiesPurchaseAgreementMember2026-01-090001435064us-gaap:SubsequentEventMemberCETX:SecuritiesPurchaseAgreementMember2026-12-092026-12-090001435064us-gaap:SubsequentEventMemberCETX:SecuritiesPurchaseAgreementMemberus-gaap:CommonStockMember2026-01-092026-01-090001435064us-gaap:SubsequentEventMemberCETX:SecuritiesPurchaseAgreementMemberus-gaap:WarrantMember2026-01-090001435064us-gaap:CommonStockMemberus-gaap:SubsequentEventMember2026-01-012026-01-310001435064CETX:SeriesBWarrantMemberus-gaap:SubsequentEventMember2026-01-310001435064us-gaap:SubsequentEventMember2026-01-31iso4217:USDxbrli:sharesiso4217:USDxbrli:sharesxbrli:pureutr:sqftCETX:Integer

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM10-Q

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES ACT OF 1934

 

For the quarterly period ended December 31, 2025

 

OR

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES ACT OF 1934

 

For the transition period from ___________to ____________

 

Commission File Number 001-37464

 

 

CEMTREX, INC.

(Exact name of registrant as specified in its charter)

 

Delaware 30-0399914

(State or other jurisdiction

of incorporation or organization)

 

(I.R.S. Employer

Identification No.)

 

135 Fell Ct. Hauppauge, NY 11788
(Address of principal executive offices) (Zip Code)

 

631-756-9116

(Registrant’s telephone number, including area code)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class Trading symbol Name of each exchange on which registered
Common Stock CETX Nasdaq Capital Market

 

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

 

Yes ☐ No

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).

 

Yes ☐ No

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

 Large accelerated filer ☐Accelerated filer ☐
 Non-accelerated filerSmaller reporting company
  Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

 

☐ Yes No

 

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date:

As of February 13, 2026, the issuer had 10,078,089 shares of common stock issued and outstanding.

 

 

 

 

 

 

CEMTREX, INC. AND SUBSIDIARIES

 

INDEX

 

  Page
   
PART I. FINANCIAL INFORMATION 
   
Item 1. Financial Statements 
   
 Condensed Consolidated Balance Sheets as of December 31, 2025 (Unaudited) and September 30, 20253
   
 Condensed Consolidated Statements of Operations for the three months ended December 31, 2025 and 2024 (Unaudited)4
   
 Condensed Consolidated Statements of Comprehensive Loss for the three months ended December 31, 2025 and 2024 (Unaudited)5
   
 Condensed Consolidated Statement of Stockholders’ Equity for the three months ended December 31, 2025 (Unaudited)6
   
 Condensed Consolidated Statement of Stockholders’ Equity for the three months ended December 31, 2024 (Unaudited)7
   
 Condensed Consolidated Statements of Cash Flow for the three months ended December 31, 2025 and 2024 (Unaudited)8
   
 Notes to Unaudited Condensed Consolidated Financial Statements10
   
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations27
   
Item 4. Controls and Procedures31
   
PART II. OTHER INFORMATION 
   
Item 1. Legal Proceedings32
   
Item 1A. Risk Factors32
   
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds32
   
Item 3. Defaults Upon Senior Securities32
   
Item 4. Mine Safety Disclosures32
   
Item 5. Other Information32
   
Item 6. Exhibits33
   
SIGNATURES34

 

2

 

 

Part I. Financial Information

 

Item 1. Financial Statements

 

Cemtrex, Inc. and Subsidiaries

Condensed Consolidated Balance Sheets

 

  (Unaudited)    
  December 31,  September 30, 
  2025  2025 
Assets        
Current assets        
Cash and cash equivalents $20,505,781  $4,974,303 
Restricted cash  1,276,752   1,372,738 
Trade receivables, net  9,702,315   13,133,424 
Trade receivables, net - related party  527,877   405,493 
Inventory, net  7,436,132   6,584,944 
Contract assets, net  1,697,691   980,164 
Prepaid expenses and other current assets  1,566,411   1,556,432 
Total current assets  42,712,959   29,007,498 
         
Property and equipment, net  9,428,532   9,651,996 
Right-of-use operating lease assets  2,110,908   2,003,967 
Royalties receivable, net - related party  56,696   190,475 
Digital assets  699,006   1,158,238 
Goodwill  3,708,347   3,708,347 
Other  1,614,101   2,067,755 
Total Assets $60,330,549  $47,788,276 
         
Liabilities & Stockholders’ Equity        
Current liabilities        
Accounts payable $4,309,111  $4,492,859 
Sales tax payable  22,416   76,008 
Revolving line of credit  1,948,258   3,176,096 
Current maturities of long-term liabilities  4,714,398   8,925,497 
Operating lease liabilities - short-term  989,401   918,391 
Deposits from customers  152,188   158,344 
Accrued expenses  1,566,280   2,223,521 
Accrued payable on inventory in transit  762,821   652,179 
Contract liabilities  1,542,262   1,655,055 
Deferred revenue  1,255,139   1,383,036 
Accrued income taxes  702,141   162,173 
Total current liabilities  17,964,415   23,823,159 
Long-term liabilities        
Long-term debt  8,039,437   4,586,779 
Long-term operating lease liabilities  1,183,916   1,153,221 
Other long-term liabilities  290,000   289,483 
Deferred revenue - long-term  428,332   482,978 
Warrant liabilities  3,333,860   8,735,197 
Total long-term liabilities  13,275,545   15,247,658 
Total liabilities  31,239,960   39,070,817 
         
Commitments and contingencies  -   - 
         
Stockholders’ equity        
Preferred stock , $0.001par value, 10,000,000shares authorized, Series 1 3,000,000shares authorized, 2,840,919shares issued and 2,776,819shares outstanding as of December 31, 2025 and 2,705,327shares issued and 2,641,227shares outstanding as of September 30, 2025 (liquidation value of $10per share)  2,841   2,705 
Preferred stock, value  2,841   2,705 
Series C, 100,000 shares authorized, 50,000 shares issued and outstanding at December 31, 2025 and September 30, 2025  50   50 
Common stock, $0.001 par value, 70,000,000 shares authorized, 8,600,552 shares issued and outstanding at December 31, 2025 and 830,606 shares issued and outstanding at September 30, 2025  8,601   831 
Additional paid-in capital  147,309,421   105,668,565 
Accumulated deficit  (119,953,888)  (99,397,741)
Treasury stock, 64,100 shares of Series 1 Preferred Stock at December 31, 2025, and September 30, 2025  (148,291)  (148,291)
Accumulated other comprehensive income  1,871,855   2,591,340 
Total stockholders’ equity  29,090,589   8,717,459 
         
Total liabilities and stockholders’ equity $60,330,549  $47,788,276 

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

3

 

 

Cemtrex, Inc. and Subsidiaries

Condensed Consolidated Statements of Operations

(Unaudited)

 

  December 31, 2025  December 31, 2024 
  For the three months ended
  December 31, 2025  December 31, 2024 
Revenues $16,133,311  $13,739,899 
Cost of revenues  10,511,445   8,037,963 
Gross profit  5,621,866   5,701,936 
Operating expenses        
General and administrative  7,926,591   7,093,289 
Research and development  501,435   890,083 
Total operating expenses  8,428,026   7,983,372 
Operating loss  (2,806,160)  (2,281,436)
Other income/(expense)        
Other income/(expense), net  35,255   34,973 
Interest expense  (12,123,695)  (483,913)
Changes in fair value of digital assets  (469,860)  - 
Loss on exercise of warrant liabilities  (4,674,806)  (15,796,105)
Changes in fair value of warrant liability  (282,546)  (10,020,212)
Total other income/(expense), net  (17,515,652)  (26,265,257)
Net loss before income taxes  (20,321,812)  (28,546,693)
Income tax expense  266,326   120,538 
Loss from continuing operations  (20,588,138)  (28,667,231)
Income/(loss) from discontinued operations, net of tax  31,991   (267,288)
Net loss  (20,556,147)  (28,934,519)
Less net loss in noncontrolling interest  -   (180,152)
Net loss attributable to Cemtrex, Inc. stockholders $(20,556,147) $(28,754,367)
Income/(loss) per share - Basic & Diluted        
Continuing Operations $(7.91) $(383.87)
Discontinued Operations $0.01  $(3.60)
Weighted Average Number of Shares-Basic & Diluted  2,601,444   74,210 

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

4

 

 

Cemtrex, Inc. and Subsidiaries

Condensed Consolidated Statements of Comprehensive Loss

(Unaudited)

 

  December 31, 2025  December 31, 2024 
  For the three months ended
  December 31, 2025  December 31, 2024 
Other comprehensive loss        
Net loss $(20,556,147) $(28,934,519)
Foreign currency translation loss  (719,485)  (131,439)
Comprehensive loss  (21,275,632)  (29,065,958)
Less net loss in noncontrolling interest  -   (180,152)
Comprehensive loss attributable to Cemtrex, Inc. stockholders $(21,275,632) $(28,885,806)

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

5

 

 

Cemtrex, Inc. and Subsidiaries

Condensed Consolidated Statement of Stockholders’ Equity

(Unaudited)

 

  Number of Shares  Amount  Number of
Shares
  Amount  Number of
Shares
  Amount   Paid-in
Capital
  Accumulated Deficit  

Preferred Stock

  

Comprehensive Income

  

Stockholders’Equity

 
  Preferred Stock Series 1 Par Value $0.001  Preferred Stock Series C Par Value $0.001  Common Stock Par
Value $0.001
  Additional     Treasury Stock, 64,100 shares of Series 1  Accumulated other  Cemtrex 
  Number of Shares  Amount  Number of
Shares
  Amount  Number of
Shares
  Amount   Paid-in
Capital
  Accumulated Deficit  

Preferred Stock

  

Comprehensive Income

  

Stockholders’Equity

 
Balance at September 30, 2025  2,705,327  $2,705         50,000  $     50   830,606  $831  $105,668,565  $(99,397,741) $(148,291) $2,591,340  $8,717,459
Foreign currency translation loss                                      (719,485)  (719,485)
Dividends paid in Series 1 preferred shares  135,592   136                   (136)              - 
Shares issued to pay debt                  3,000,296   3,001   19,639,282               19,642,283 
Exercise of Series A warrants                  29,943   30   211,068               211,098 
Exercise of Series B warrants                  2,316,480   2,317   15,802,537               15,804,854 
Shares issued in offering                  2,355,556   2,356   5,988,171               5,990,527 
Issuance of roundup shares                  67,671   66   (66)              - 
Net loss          -   -               (20,556,147)  -       (20,556,147)
Balance at December 31, 2025  2,840,919  $2,841   50,000  $50   8,600,552  $8,601  $147,309,421  $(119,953,888) $(148,291) $1,871,855  $29,090,589

 

6

 

 

Cemtrex, Inc. and Subsidiaries

Condensed Consolidated Statement of Stockholders’ Equity (Continued)

(Unaudited)

 

  Number of
Shares
  Amount  Number of
Shares
  Amount  Number of
Shares
  Amount  Paid-in Capital  

Accumulated

Deficit

   Preferred Stock  

Comprehensive Income

   Stockholders’ Equity  Non-controlling
interest
 
  Preferred Stock Series 1
Par Value $0.001
 Preferred Stock Series C Par Value $0.001 Common Stock Par
Value $0.001
 Additional     Treasury Stock, 64,100 shares of Series 1  Accumulated other  Cemtrex    
  Number of
Shares
  Amount  Number of
Shares
  Amount  Number of
Shares
  Amount  Paid-in Capital  

Accumulated

Deficit

   Preferred Stock  

Comprehensive Income

   Stockholders’ Equity  Non-controlling
interest
 
Balance at September 30, 2024  2,456,827  $2,457         50,000  $50              946  $1  $73,262,549  $(71,355,386) $(148,291) $2,949,297  $4,710,677  $250,165 
Balance  2,456,827  $2,457         50,000  $50              946  $1  $73,262,549  $(71,355,386) $(148,291) $2,949,297  $4,710,677  $250,165 
Foreign currency translation loss                                      (131,439)  (131,439)    
Share-based compensation                          4,087               4,087     
Dividends paid in Series 1 preferred shares  123,167   123                   (123)              -     
Exercise of Series A warrants                  88,492   89   21,515,688               21,515,777     
Exercise of Series B warrants                  22,244   22   1,095,709               1,095,731     
Issuance of roundup shares                  7,299   7   (7)              -     
Loss attributable to noncontrolling interest                                          -   (180,152)
Net loss          -   -               (28,754,367)  -       (28,754,367)    
Balance at December 31, 2024  2,579,994  $2,580   50,000  $50   118,981  $119  $95,877,903  $(100,109,753) $(148,291) $2,817,858  $(1,559,534) $70,013 
Balance  2,579,994  $2,580   50,000  $50   118,981  $119  $95,877,903  $(100,109,753) $(148,291) $2,817,858  $(1,559,534) $70,013 

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

7

 

 

Cemtrex, Inc. and Subsidiaries

Condensed Consolidated Statements of Cash Flows

(Unaudited)

 

  2025  2024 
  

For the three months ended

December 31,

  2025  2024 
Cash Flows from Operating Activities      
Net loss $(20,556,147) $(28,934,519)
         
Adjustments to reconcile net loss to net cash used by operating activities        
Depreciation and amortization  412,395   337,259 
(Gain)/loss on disposal of property and equipment  (523)  18,846 
Noncash lease expense  257,769   254,695 
Credit loss recovery  (8,506)  (7,367)
Contract modification - related party  -   280,545 
Share-based compensation  -   4,087 
Write-off of demonstration equipment  441,624   - 
Interest expense paid in equity shares  11,798,283   - 
Accrued interest on notes payable  162,713   262,107 
Non-cash royalty income  (31,991)  (13,797)
Amortization of original issue discounts on notes payable  12,500   4,167 
Loan origination costs  25,000   5,000 
Receipt of SOL from staking  (13,138)  - 
Non-cash transaction fees  2,510   - 
Unrealized loss on digital assets  469,860   - 
Loss on exercise of warrant liabilities  4,674,806   15,796,105 
Changes in fair value of warrant liability  282,546   10,020,212 
         
Changes in operating assets and liabilities net of effects from acquisition of subsidiaries:        
Trade receivables  3,440,800   1,964,241 
Trade receivables - related party  13,386   66,057 
Inventory  (851,188)  (4,126,906)
Contract assets  (718,712)  (556,032)
Prepaid expenses and other current assets  (9,979)  261,559 
Other assets  112,030   157,699 
Accounts payable  (183,748)  (1,051,056)
Sales tax payable  (53,592)  (63,509)
Operating lease liabilities  (263,005)  (256,271)
Deposits from customers  (6,156)  (88,285)
Accrued expenses  (546,600)  4,743,926 
Contract liabilities  (112,793)  24,981 
Deferred revenue  (182,543)  (188,930)
Income taxes payable  539,968   (149,142)
Other liabilities  517   32,511 
Net cash used in operating activities  (891,914)  (1,201,817)
         
Cash Flows from Investing Activities      
Purchase of property and equipment  (183,584)  (924,428)
Proceeds from sale of property and equipment  523   5,529 
Royalties on related party revenues  30,000   10,000 
Purchase of marketable securities  (100,000)  - 
Investment in MasterpieceVR  -   (100,000)
Net cash used by investing activities  (253,061)  (1,008,899)
         
Cash Flows from Financing Activities      
Proceeds on revolving line of credit  7,285,840   7,025,841 
Payments on revolving line of credit  (8,513,678)  (6,053,954)
Payments on debt  (114,654)  (124,912)
Payments on Paycheck Protection Program Loans  -   (10,123)
Proceeds from notes payable  7,000,000   500,000 
Proceeds from warrant exercises  5,657,264   1,050,597 
Proceeds from offerings  6,000,000   - 
Expenses on offerings  (9,473)  - 
Net cash provided by financing activities  17,305,299   2,387,449 
         
Effect of currency translation  (724,832)  (132,871)
Net increase in cash, cash equivalents, and restricted cash  16,160,324   176,733 
Cash, cash equivalents, and restricted cash at beginning of period  6,347,041   5,420,392 
Cash, cash equivalents, and restricted cash at end of period $21,782,533  $5,464,254 

 

8

 

 

Cemtrex, Inc. and Subsidiaries

Condensed Consolidated Statements of Cash Flows (Continued)

(Unaudited)

 

  December 31, 2025  December 31, 2024 
Balance Sheet Accounts Included in Cash, Cash Equivalents, and Restricted Cash      
Cash and cash equivalents $20,505,781  $4,224,130 
Restricted cash  1,276,752   1,240,124 
Total cash, cash equivalents, and restricted cash $21,782,533  $5,464,254 

 

         
  

For the three months ended

December 31,

  2025  2024 
Supplemental Disclosure of Cash Flow Information:      
Cash paid during the period for interest $150,199  $217,639 
Cash paid during the period for income taxes, net of refunds $-  $269,680 
         
Supplemental Schedule of Non-Cash Investing and Financing Activities      
Shares issued to pay notes payable $19,642,283  $- 
Noncash dividends $136  $123 
Noncash recognition of new leases $364,710  $159,086 
Series A Warrant Exercises $211,098  $21,515,777 
Series B Warrant Exercises $15,804,854  $- 

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

9

 

 

Cemtrex, Inc. and Subsidiaries

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

 

NOTE 1 – ORGANIZATION AND PLAN OF OPERATIONS

 

Cemtrex was incorporated in 1998 in the state of Delaware and has evolved through strategic acquisitions and internal growth into a leading multi-industry company. Unless the context requires otherwise, all references to “we”, “our”, “us”, “Company”, “registrant”, “Cemtrex” or “management” refer to Cemtrex, Inc. and its subsidiaries.

 

The Company’s reporting segments consist of Security and Industrial Services. Additionally, the Company’s operational structure also reports unallocated corporate expenses.

 

Security

 

Cemtrex’s Security segment operates under the brand of its subsidiary, Vicon Industries, Inc. (“Vicon”), which provides end-to-end security solutions to meet the toughest corporate, industrial, and governmental security challenges. Vicon’s products include browser-based video monitoring systems and analytics-based recognition systems, cameras, servers, and access control systems for every aspect of security and surveillance in industrial and commercial facilities, federal prisons, hospitals, universities, schools, and federal and state government offices. Vicon provides innovative, mission critical security and video surveillance solutions utilizing Artificial Intelligence (AI) based data algorithms.

 

Industrial Services

 

Cemtrex’s Industrial Services segment operates under the brand, Advanced Industrial Services (“AIS”), which offers single-source expertise and services for rigging, millwrighting, in plant maintenance, equipment erection, relocation, and disassembly to diversified customers. AIS installs high precision equipment in a wide variety of industrial markets like automotive, printing & graphics, industrial automation, packaging, and chemicals, among others. AIS is a leading provider of reliability-driven maintenance and contracting solutions for machinery, packaging, printing, chemical, and other manufacturing markets. We help customers seeking to achieve greater asset utilization and reliability to cut costs and increase production from existing assets, including small projects, sustaining capital, turnarounds, maintenance, specialty welding services, and high-quality scaffolding.

 

Common Stock Reverse Stock Split

 

On October 2, 2024, November 26, 2024, and September 29, 2025, the Company completed 60:1, 35:1, and 15:1 respectively, reverse stock split on its common stock. All share and per share data have been retroactively adjusted for the reverse splits.

 

Additionally, there was an error in the calculation of the weighted average shares for the three months ended December 31, 2024, for the reverse stock splits on October 2, 2024, and November 26, 2024, the following table summarizes the correction prior to the adjustment for the reverse stock split on September 29, 2025.

SCHEDULE OF ERROR CORRECTION REVERSE STOCK SPLIT

          
  As previously reported  

For the three
months ended
December 31, 2024
Corrections

  As corrected 
          
(Loss)/income per share - Basic & Diluted            
Continuing Operations $(16.15) $(9.44) $(25.59)
Discontinued Operations $(0.15) $(0.09) $(0.24)
Weighted Average Number of Shares-Basic & Diluted  1,764,341   (651,203)  1,113,138 

 

This error affected the calculation of the weighted average shares at September 30, 2025, the following table summarizes the correction.

 

  As previously reported  

For the year ended
September 30, 2025

Corrections

  As corrected 
          
(Loss)/income per share - Basic & Diluted            
Continuing Operations $(210.88) $56.56  $(154.32)
Discontinued Operations $(1.84) $0.50  $(1.34)
Weighted Average Number of Shares-Basic & Diluted  132,396   48,794   181,190 

 

Acquisitions

 

On January 8, 2026, the Company completed the acquisition of Invocon. As a result of the transaction, Invocon became a wholly owned subsidiary of the Company. The purchase price of $7,060,000 was paid in cash at closing. Invocon will launch of the Company’s Aerospace and Defense segment with reporting results beginning in the second quarter of fiscal year 2026.

 

On February 5, 2026, the Company, through its subsidiary AIS, acquired substantially all the assets of Richland Industries LLC (“Richland”), an industrial services and fabrication company located in Tennessee. In connection with the transaction, AIS established a new subsidiary, AIS as part of the Company’s Industrial Services Segment. The purchase price of $600,000 was paid via a note payable issued by Fulton Bank. This note carries interest of 6.09% and matures on February 1, 2031. In addition, the Company purchased Richland’s primary facility for $4,900,000 via a $3,920,000 mortgage issued by Fulton Bank and the balance including taxes, closing costs, and fees in cash. This mortgage has carries interest of SOFR plus 2.75% and matures on February 1, 2041.

 

10

 

 

Going Concern Considerations

 

The accompanying unaudited condensed consolidated financial statements of the Company have been prepared assuming the Company will continue as a going concern and in accordance with generally accepted accounting principles in the United States of America. The going concern basis of presentation assumes that the Company will continue in operation one year after the date these financial statements are issued and will be able to realize its assets and discharge its liabilities and commitments in the normal course of business. Pursuant to the requirements of the ASC 205, management must evaluate whether there are conditions or events, considered in the aggregate, which raise substantial doubt about the Company’s ability to continue as a going concern for one year from the date these financial statements are issued.

 

This evaluation does not take into consideration the potential mitigating effect of management’s plans that have not been fully implemented or are not within control of the Company as of the date the financial statements are issued. When substantial doubt exists under this methodology, management evaluates whether the mitigating effect of its plans sufficiently alleviates substantial doubt about the Company’s ability to continue as a going concern. The mitigating effect of management’s plans, however, is only considered if both (1) it is probable that the plans will be effectively implemented within one year after the date that the financial statements are issued, and (2) it is probable that the plans, when implemented, will mitigate the relevant conditions or events that raise substantial doubt about the entity’s ability to continue as a going concern within one year after the date that the financial statements are issued.

 

The Company has incurred substantial losses of $28,112,368 and $7,229,491 for fiscal years 2025 and 2024, respectively and a loss of $20,556,147for the three months ended December 31, 2025, and has debt obligations over the next fiscal year of $6,662,656 that raise substantial doubt with respect to the Company’s ability to continue as a going concern.

 

While the Company’s losses and current debt indicate a substantial doubt regarding the Company’s ability to continue as a going concern, the Company has historically, from time to time, satisfied and may continue to satisfy certain short-term liabilities through the issuance of common stock, thus reducing our cash requirement to meet our operating needs. These transactions add additional significant non-operational expenses which are non-cash in nature. The Company has $20,505,781 in cash and cash equivalents as of December 31, 2025. Additionally, the Company has (i) secured a line of credit for its Vicon brand to fund operations, which as of December 31, 2025, has available capacity of approximately $420,000, (ii) continually reevaluate our pricing model on the Company’s Vicon brand to improve margins on those products, (iii) raised $5,657,264 through the exercise of our Series B warrants during the quarter ended December 31, 2025 (iv) raised $6,000,000 in gross proceeds in equity offering during the quarter ended December 31, 2025, and an additional $4,000,000in gross proceeds subsequent to December 31, 2025. In the event additional capital is raised through equity offerings and/or debt is satisfied with equity, it may have a dilutive effect on our existing stockholders. While the Company believes these plans, if successful, would be sufficient to meet the capital demands of the Company’s current operations for at least the next twelve months, there is no guarantee that the Company will succeed.

 

Overall, there is no guarantee that cash flow from our existing or future operations and any external capital that we may be able to raise will be sufficient to meet our working capital needs. The Company currently does not have adequate cash or available liquidity/available capacity on our lines of credit to meet our long-term needs and our above plans in the short term may prove to be inadequate to continue as a going concern. Thus, despite our cash on hand, our ability to draw on our credit line, or changes to our pricing models, and other safeguards, we may be unable to meet our obligations as they become due over the next twelve months beyond the issuance date. The unaudited condensed consolidated financial statements do not include any adjustments relating to this uncertainty.

 

NOTE 2 – INTERIM STATEMENT PRESENTATION

 

Basis of Presentation and Use of Estimates

 

The accompanying unaudited condensed consolidated financial information should be read in conjunction with the audited consolidated financial statements and the notes thereto included in the Company’s Annual Report on Form 10-K for the year ended September 30, 2025.

 

11

 

 

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the Unites States (“U.S. GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X pursuant to the requirements of the U.S. Securities and Exchange Commission (‘SEC”). Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring adjustments) considered necessary for a fair presentation have been included. The results of operations for the interim periods are not necessarily indicative of the results of operations for the entire year.

 

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities as of the date of the condensed consolidated financial statements, the disclosure of contingent assets and liabilities in the condensed consolidated financial statements and the accompanying notes, and the reported amounts of revenues, expenses and cash flows during the periods presented. Actual amounts and results could differ from those estimates. The estimates and assumptions the Company makes are based on historical factors, current circumstances and the experience and judgment of the Company’s management. The Company evaluates its estimates and assumptions on an ongoing basis.

 

Significant Accounting Policies

 

Note 2 of the Notes to Consolidated Financial Statements, included in the annual report on Form 10-K for the year ended September 30, 2025, includes a summary of the significant accounting policies used in the preparation of the unaudited condensed consolidated financial statements.

 

Recently Adopted Accounting Pronouncements

 

In December 2023, the FASB issued ASU 2023-09, “Income Taxes (Topic 740): Improvements to Income Tax Disclosures,” which requires public entities to disclose consistent categories and greater disaggregation of information in the rate reconciliation and for income taxes paid. It also includes certain other amendments to improve the effectiveness of income tax disclosures. The guidance is effective for financial statements issued for annual periods beginning after December 15, 2024, with early adoption permitted. The Company adopted this standard on October 1, 2025. There has been no material effect on the unaudited condensed consolidated financial statements.

 

Recently Issued Accounting Pronouncements Not Yet Effective

 

In October 2023, the FASB issued ASU 2023-06, Disclosure Improvements: Codification Amendments in Response to the SEC’s Disclosure Update and Simplification Initiative, to amend certain disclosure and presentation requirements for a variety of topics within the Accounting Standards Codification (“ASC”). These amendments align the requirements in the ASC to the removal of certain disclosure requirements set out in Regulation S-X and Regulation S-K, announced by the SEC. The effective date for each amended topic in the ASC is the date on which the SEC’s removal of the related disclosure requirement from Regulation S-X or Regulation S-K becomes effective. Early adoption is prohibited. The Company does not anticipate that the ASU will have a material effect on the Company’s unauditedfinancial statements and related disclosures.

 

In November 2024, the FASB issued ASU 2024-03, “Income Statement (Topic 220): Reporting Comprehensive Income - Expense Disaggregation Disclosures, Disaggregation of Income Statement Expenses”, that requires public companies to disclose, in interim and reporting periods, additional information about certain expenses in the financial statements. ASU 2024-03 is effective for annual periods beginning after December 15, 2026, and interim reporting periods beginning after December 15, 2027. Early adoption is permitted and is effective on either a prospective basis or retrospective basis. The Company is currently assessing the potential impacts of adoption on the unaudited condensed consolidated financial statements.

 

In November 2024, the FASB issued ASU 2024-04, “Debt with Conversion and Other Options (Subtopic 470-20), which clarifies the requirements for determining whether certain settlements of convertible debt instruments should be accounted for as an induced conversion. ASU 2024-04 is effective for annual periods beginning after December 15, 2025, and interim reporting periods within those annual reporting periods. Early adoption is permitted for all entities that have adopted the amendments in Update 2020-06. Adoption can be on a prospective or retrospective basis. The Company is currently in the process of evaluating the impact of adoption on the unaudited condensed consolidated financial statements.

 

12

 

 

In July 2025, the FASB issued ASU 2025-05, Financial Instruments—Credit Losses (Topic 326). This guidance contains amendments that provide decision-useful information to investors and other financial statement users while reducing the time and effort necessary to analyze and estimate credit losses for current accounts receivable and current contract assets. The amendments will be effective for annual reporting periods beginning after December 15, 2025, and interim reporting periods within those annual reporting periods. Early adoption is permitted in both interim and annual reporting periods in which financial statements have not yet been issued or made available for issuance. The Company is currently evaluating the impact of ASU 2025-05 on its unaudited condensed consolidated financial statements and related disclosures.

 

In December 2025, the FASB issued ASU 2025-11 - Interim Reporting (“ASU 2025-11”) which is intended to improve the navigability of the guidance in ASC 270, Interim Reporting, and clarify when it applies. Under the amendments, an entity is subject to ASC 270 if it provides interim financial statements and notes in accordance with GAAP. ASU 2025-11 also addresses the form and content of such financial statements, interim disclosures requirements, and establishes a principle under which an entity must disclose events since the end of the last annual reporting period that have a material impact on the entity. ASU 2025-11 is effective for interim reporting periods within annual reporting periods beginning after December 15, 2027, and early adoption is permitted. The Company is currently evaluating the impact the adoption of ASU 2025-11 may have on the Company’s unaudited consolidated financial statements.

 

The Company does not believe that any other recently issued but not yet effective accounting pronouncements, if adopted, would have a material effect on the accompanying unaudited condensed consolidated financial statements.

 

NOTE 3 – REVENUE

 

The following table illustrates the approximate disaggregation of the Company’s revenue based off timing of revenue recognition for the three months ended December 31, 2025, and 2024:

 SCHEDULE OF DISAGGREGATION OF REVENUE RECOGNITION

  
2025
  
2024
 
  For the three months ended
  December 31,
2025
  December 31,
2024
 
Over time  70%  66%
Point-in-time  30%  34%
Revenue performance obligation percentage  30%  34%

 

NOTE 4 – LOSS PER COMMON SHARE

 

Basic net loss per common share is computed by dividing net loss by the weighted average number of shares of common stock outstanding during the period. Diluted net loss per common share is computed by dividing net income by the weighted average number of shares of common stock and potentially dilutive outstanding shares of common stock during the period to reflect the potential dilution that could occur from common shares issuable through contingent share arrangements, stock options and warrants. For the three months ended December 31, 2025, and 2024, the following items were excluded from the computation of diluted net loss per common share as their effect is anti-dilutive:

 SCHEDULE OF COMPUTATION OF DILUTED NET LOSS PER COMMON SHARE AS ANTI-DILUTIVE EFFECT

  
2025
  
2024
 
  For the three months ended
  December 31,
2025
  December 31,
2024
 
Options  7   7 
Warrants  1,068,339   3,318,556 
Anti-dilutive shares  1,068,339   3,318,556 

 

13

 

 

For the three months ended December 31, 2025, and 2024, loss per share basic and diluted for continuing operations are calculated as follows:

 SCHEDULE OF LOSS PER SHARE BASIC AND DILUTED FOR CONTINUING OPERATIONS

  2025  2024 
  

For the three months ended

December 31,

  2025  2024 
Loss from Continuing operations $(20,588,138) $(28,667,231)
Less loss in noncontrolling interest  -   (180,152)
Net loss applicable to common shareholders  (20,588,138)  (28,487,079)
Weighted Average Number of Shares-Basic & Diluted  2,601,444   74,210 
Loss per share - Basic & Diluted - Continuing Operations $(7.91) $(383.87)

 

In accordance with ASC 260-45-13, the common shares underlying the Series A Warrants under the alternative cashless exercise have been included in the calculation of the weighted average shares.

 

NOTE 5 – SEGMENT INFORMATION

 

The Company reports and evaluates financial information for two reportable segments: the Security segment and the Industrial Services segment. The Chief Operating Decision Maker (“CODM”) for all segments is Saagar Govil, the CEO of the Company.

 

Unallocated corporate expenses mainly relate to payroll and benefits for corporate officers, investor relation expenses, accounting expenses related to audit and taxes, legal expenses related to corporate matters, interest expense on notes payable, and Series A and B Warrants transaction losses.

 

The following tables summarize the Company’s reportable segment information and unallocated corporate expenses:

 SCHEDULE OF SEGMENT INFORMATION

                         
  For the three months ended December 31, 2025 For the three months ended December 31, 2024
  Reportable Segments      Reportable Segments     
  Security  Industrial Services  Corporate  Consolidated  Security  Industrial Services  Corporate  Consolidated 
External revenues $5,511,528  $10,611,156  $10,627  $16,133,311  $5,453,699  $8,286,200  $-  $13,739,899 
Cost of revenues  3,350,760   7,160,685   -   10,511,445   2,613,940   5,424,023   -   8,037,963 
Gross profit $2,160,768  $3,450,471  $10,627  $5,621,866  $2,839,759  $2,862,177  $-  $5,701,936 
Operating expenses                                
General, and administrative  4,603,923   1,789,739   1,209,628   7,603,290   3,759,298   1,761,403   1,234,865   6,755,566 
Depreciation and amortization  80,036   243,265   -   323,301   86,023   251,700   -   337,723 
Research and development  501,435   -   -   501,435   890,083   -   -   890,083 
Operating income/(loss) $(3,024,626) $1,417,467  $(1,199,001) $(2,806,160) $(1,895,645) $849,074  $(1,234,865) $(2,281,436)
                                 
Other expense, net $(64,174) $(49,417) $(17,402,061) $(17,515,652) $(392,917) $(78,226) $(25,794,114) $(26,265,257)

 

The following table summarizes the Company’s identifiable assets by segment as of December 31, 2025, and September 30, 2025.

 

  December 31,  September 30, 
  2025  2025 
Identifiable Assets        
Security $14,731,143  $17,334,365 
Industrial Services  25,449,815   25,865,577 
Corporate  20,149,591   4,588,334 
Total Assets $60,330,549  $47,788,276 

 

14

 

 

NOTE 6 – RESTRICTED CASH

 

A subsidiary of the Company participates in a consortium in order to self-insure group care coverage for its employees. The plan is administrated by Benecon Group, and the Company makes monthly deposits in a trust account to cover medical claims and any administrative costs associated with the plan. Additionally, there was restricted cash in escrow per the purchase agreement with Heisey Mechanical, Ltd. Additionally, there are funds in escrow related to bond requirements on certain public projects and deposit guarantees.

 

The Company’s restricted cash as of December 31, 2025, and September 30, 2025, are summarized below.

 SCHEDULE OF RESTRICTED CASH

  December 31,  September 30, 
  2025  2025 
Benecon group $905,331  $839,215 
Heisey escrow  -   100,000 
Bond escrow  304,146   366,319 
Deposit guarantees  67,275   67,204 
Escrow deposit  67,275   67,204 
Restricted cash $1,276,752  $1,372,738 

 

NOTE 7 – FAIR VALUE MEASUREMENTS

 

Fair value is defined as the price that would be received upon sale of an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. A three-level hierarchy is applied to prioritize the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements).

 

The three levels of the fair value hierarchy under the guidance for fair value measurements are described below:

 

Level 1 — Level 1 inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date. Our Level 1 assets include cash equivalents, banker’s acceptances, trading securities, investments, and investment funds. The Company measures trading securities investments and investment funds at quoted market prices as they are traded in an active market with sufficient volume and frequency of transactions.

 

Level 2 — Level 2 inputs are inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly. If the asset or liability has a specified contractual term, a Level 2 input must be observable for substantially the full term of the asset or liability.

 

Level 3 — Level 3 inputs are unobservable inputs for the asset or liability in which there is little, if any, market activity for the asset or liability at the measurement date. Level 3 assets and liabilities include cost method investments. Quantitative information for Level 3 assets and liabilities reviewed at each reporting period includes indicators of significant deterioration in the earnings performance, credit rating, asset quality, business prospects of the investee, and financial indicators of the investee’s ability to continue as a going concern.

 

15

 

 

The Company’s fair value liabilities at December 31, 2025, and September 30, 2025, are as follows.

 SCHEDULE OF FAIR VALUE OF LIABILITIES 

  

Quoted Prices in Active Markets for Identical Assets

(Level 1)

 

Significant Other Observable Inputs

(Level 2)

  

Significant Unobservable

Inputs

(Level 3)

  Balance as of December 31, 2025 
Assets                              
Digital assets - SOL$699,006 $-  $-  $699,006 
Marketable Securities$100,033 $-  $-  $100,033 
Liabilities              
Warrant liabilities$815,632 $2,518,228  $-  $3,333,860 

 

  

Quoted Prices in Active Markets for Identical Assets

(Level 1)

 

Significant Other Observable Inputs

(Level 2)

  

Significant Unobservable

Inputs (Level 3)

  Balance as of September 30, 2025 
Assets                             
Digital assets - SOL$1,158,238 $-  $-  $1,158,238 
Liabilities              
Warrant liabilities$833,854 $7,901,343  $-  $8,735,197 

 

Digital Assets – SOL

 

On July 29, 2025, the Company invested $998,642 in Solana (SOL) and staked our holdings. SOL is a fungible crypto asset that meets the criteria for an intangible asset, resides on a distributed ledger, is secured by cryptography, and does not grant enforceable rights to underlying goods or services to its holder. The digital assets were measured at fair value after acquisition, with changes reported in net income. Staking earnings are recorded as revenue.

 

Digital Asset staking allows holders of specific cryptocurrencies to earn rewards for helping to validate blocks of transaction data as it is submitted to the blockchain network.

 

The staking process serves two key purposes:

 

 Ensures the accuracy of new information as it is added to the blockchain.
   
 Helps to secure the underlying blockchain network against the majority of the network taking over control, known as a 51% attack.

 

The staking process uses incentives and penalties governed by computer-based rules to encourage honest participation in the network. Stakers who act within the rules of the protocol receive rewards for their contributions, while those who act dishonestly can face penalties, such as losing their staked cryptocurrency through a process called slashing. Staking rewards are distributed as newly minted cryptocurrency units, oftentimes at a proportionate rate to the amount a person stakes. With some proof-of-stake blockchains, depositing more assets in a staking smart contract increases the chance of being selected to validate blocks. This mechanism is based on the assumption that those with more “skin in the game” are more likely to act within the best interests of the network because they have more to lose financially if their assets are slashed (confiscated by the network). However, to avoid favoring wealthier participants, some protocols incorporate randomness to ensure everyone, including those with smaller stakes, has a chance to earn rewards.

 

16

 

 

Staking incentives, in the form of additional SOL, are recognized on the date received at the fair market value on that date. There are no lockups or restrictions on the Company’s digital asset holdings due to staking.

 

The Company’s digital assets as of December 31, 2025, and September 30, 2025, are as follows.

 SCHEDULE OF DIGITAL ASSETS HOLDINGS

  December 31,
2025
  September 30,
2025
 
Units - SOL  5,615   5,549 
Cost Per Unit $181.45  $181.70 
Cost Basis $1,018,856  $1,008,229 
Fair Value $699,006  $1,158,238 

 

The following table is a summary of our digital assets as of December 31, 2025.

 SUMMARY OF DIGITAL ASSETS

Fair Value, September 30, 2024 $- 
Cash purchase  998,462 
Receipt of SOL from staking  12,522 
Non-cash transaction fees  (2,755)
Unrealized gain  150,009 
Fair Value, September 30, 2025 $1,158,238 
Cash purchase  - 
Receipt of SOL from staking  13,138 
Non-cash transaction fees  (2,510)
Unrealized loss  (469,860)
Fair Value, December 31, 2025 $699,006 

 

Warrant Liabilities

 

The value of the Series A Warrants is based on the market value of our common stock on the balance sheet date.

 

The fair value of the Series B Warrants is estimated on the balance sheet date using the Black-Scholes model, which requires inputs based on certain subjective assumptions, including the fair value of the Company’s common shares, expected share price volatility, the expected term of the award, the risk-free interest rate for a period that approximates the expected term of the option, and the Company’s expected dividend yield.

 

At December 31, 2025, and September 30, 2025, the following inputs were used in the Black-Scholes model.

 

SCHEDULE OF FAIR VALUE INPUTS USED IN BLACK-SCHOLES MODEL

  December 31,
2025
  September 30,
2025
 
Expected term  3.33 Years   3.59 Years 
Risk-free interest rate  3.59%  3.61%
Expected volatility  180.77%  178.98%
Expected dividend yield  0.00%  0.00%
Stock Price $2.59  $5.66 

 

17

 

 

The following table summarizes information on warrant liabilities as of December 31, 2025.

 SCHEDULE OF WARRANT LIABILITIES ACTIVITY

  Series A Warrants  Series B Warrants  Total 
Warrant Liabilities at September 30, 2024 $4,160,658  $1,038,778  $5,199,436 
Warrants Issued  -   -   - 
Warrants Exercised  (5,669,909)  (1,727,742)  (7,397,651)
Fair market revaluation  2,343,105   8,590,307   10,933,412 
Warrant Liabilities at September 30, 2025 $833,854  $7,901,343  $8,735,197 
Warrant Liabilities, Beginning balance $833,854  $7,901,343  $8,735,197 
Warrants Issued  -   -   - 
Warrants Exercised  (97,615)  (5,586,268)  (5,683,883)
Fair market revaluation  69,850   212,696   282,546 
Warrant Liabilities at December 31, 2025 $806,089  $2,527,771  $3,333,860 
Warrant Liabilities, Ending balance $806,089  $2,527,771  $3,333,860 

 

NOTE 8 – TRADE RECEIVABLES, NET

 

Trade receivables, net consisted of the following:

 SCHEDULE OF TRADE RECEIVABLES, NET 

  December 31,  September 30, 
  2025  2025 
Trade receivables $9,845,039  $13,285,839 
Allowance for credit losses  (142,724)  (152,415)
Accounts receivables, net, total  $9,702,315  $13,133,424 

 

Trade receivables include amounts due for shipped products and services rendered.

 

Allowance for credit losses include estimated losses resulting from the inability of our customers to make the required payments.

 

NOTE 9 – PREPAID EXPENSES AND OTHER CURRENT ASSETS

 

Prepaid expenses and other current assets consisted of the following:

 SUMMARY OF PREPAID EXPENSES AND OTHER CURRENT ASSETS

  December 31,
2025
  September 30,
2025
 
       
Prepaid expenses $967,561  $1,327,463 
Prepaid inventory  301,869   81,820 
Deferred costs  182,233   132,434 
Short-term investments  114,748   14,715 
Prepaid expenses and other current assets total $1,566,411  $1,556,432 

 

 

NOTE 10 – INVENTORY, NET

 

Inventory, net consisted of the following:

 SCHEDULE OF INVENTORY, NET

  December 31,  September 30, 
  2025  2025 
Raw materials $696,042  $609,304 
Work in progress  644,668   364,907 
Finished goods  6,095,422   5,610,733 
Inventory, net  7,436,132   6,584,944 

 

The Company maintained an allowance for obsolete inventories of $1,042,321 and $1,034,798 at December 31, 2025, and September 30, 2025, respectively.

 

18

 

 

NOTE 11 – PROPERTY AND EQUIPMENT

 

Property and equipment are summarized as follows:

 SUMMARY OF PROPERTY AND EQUIPMENT

  December 31,  September 30, 
  2025  2025 
Land $945,279  $945,279 
Building and leasehold improvements  4,485,091   4,482,978 
Furniture and office equipment  642,849   625,995 
Computers and software  2,686,147   2,685,331 
Machinery and equipment  14,070,364   13,927,502 
Property and equipment, gross  22,829,730   22,667,085 
Less: Accumulated depreciation  (13,401,198)  (13,015,089)
Property and equipment, net $9,428,532  $9,651,996 

 

Depreciation expense for the three months ended December 31, 2025, and 2024, was $412,395 and $337,259, respectively, and is recorded in cost of revenues and general and administrative expenses on the Company’s unaudited condensed consolidated statements of operations.

 

NOTE 12 – GOODWILL

 

Changes in the carrying amount of goodwill, by segment, were as follows:

 SCHEDULE OF GOODWILL BY SEGMENT

  Security  Industrial Services  Consolidated 
Balance at September 30, 2024 $       -  $3,708,347  $3,708,347 
Impairment /adjustments  -   -   - 
Balance at September 30, 2025 $-  $3,708,347  $3,708,347 
Impairment /adjustments  -   -   - 
Balance at December 31, 2025 $-  $3,708,347  $3,708,347 

 

As of December 31, 2025, and September 30, 2025, accumulated impairment losses of $3,846,475 have been recorded related to the Security segment.

 

NOTE 13 – OTHER ASSETS

 

On November 13, 2020, and January 19, 2022, Cemtrex made $500,000 in investments, on July 18, 2023, and October 5, 2023, made additional $100,000 in investments, and on October 17, 2024, and November 18, 2024, made additional $50,000 in investments on each respective date, via a simple agreement for future equity (“SAFE”) in MasterpieceVR. The SAFE provides that the Company will automatically receive shares of the entity based on the conversion rate of future equity rounds up to a valuation cap, as defined. MasterpieceVR is a software company that is developing software for content creation using virtual reality. The investment is included in other assets in the accompanying unaudited condensed consolidated balance sheet and the Company accounts for this investment and records it at cost. No impairment has been recorded for the three months ended December 31, 2025, and 2024.

 

Other assets consisted of the following:

 SCHEDULE OF OTHER ASSETS

  December 31,
2025
  September 30,
2025
 
Rental deposits $261,897  $262,201 
Investment in Masterpiece VR  1,300,000   1,300,000 
Other deposits  52,204   63,930 
Demonstration equipment supplied to resellers  -   441,624 
Other assets total $1,614,101  $2,067,755 

 

19

 

 

NOTE 14 – ACCRUED EXPENSES

 

Accrued expenses consisted of the following:

 SCHEDULE OF ACCRUED EXPENSES

  December 31,
2025
  September 30,
2025
 
Accrued expenses $283,672  $442,344 
Accrued payroll and payroll taxes  1,059,906   1,558,475 
Accrued warranty  222,702   222,702 
Accrued expenses total $1,566,280  $2,223,521 

 

NOTE 15 – DEFERRED REVENUE

 

The Company’s deferred revenue for the three months ended December 31, 2025, and 2024, were as follows:

SCHEDULE OF DEFERRED REVENUE 

  For the three months ended
  December 31, 2025  December 31, 2024 
       
Deferred revenue at beginning of period $1,866,014  $1,955,635 
Net additions:        
Deferred software revenues  374,100   364,145 
Recognized as revenue:        
Deferred software revenues  (556,643)  (553,075)
Deferred revenue at end of period  1,683,471   1,766,705 
Less: current portion  1,255,139   1,206,052 
Long-term deferred revenue at end of period $428,332  $560,653 

 

For the three months ended December 31, 2025, and 2024, the Company recognized revenue of $499,890, and $501,666, respectively, that was previously included in the beginning balance of deferred revenues.

 

NOTE 16 – CONTRACT ASSETS AND LIABILITIES

 

Project contracts typically provide for a schedule of billings on percentage of completion of specific tasks inherent in the fulfillment of the Company’s performance obligation(s). The schedules for such billings usually do not precisely match the schedule on which costs are incurred. As a result, contract revenue recognized in the statements of operations can and usually does differ from amounts that can be billed to the customer at any point during the contract. Amounts by which cumulative contract revenue recognized on a contract as of a given date exceeds cumulative billings and unbilled receivables to the customer under the contract are reflected as a current asset in the unaudited condensed consolidated balance sheets under the caption “Contract assets.” Amounts by which cumulative billings to the customer under a contract as of a given date exceed cumulative contract revenue recognized are reflected as a current liability in the unaudited condensed consolidated balance sheets under the caption “Contract liabilities.” Conditional retainage represents the portion of the contract price withheld until the work is substantially complete for assurance of the Company’s obligations to complete the job.

 

The following is a summary of the Company’s uncompleted contracts:

SCHEDULE OF CONTRACT ASSETS AND LIABILITIES 

  December 31,
2025
  September 30,
2025
 
Costs incurred on uncompleted contracts $14,433,807  $10,344,923 
Estimated gross profit  5,411,216   4,025,531 
   19,845,023   14,370,454 
Applicable billings to date  (19,689,594)  (15,045,345)
Net earnings in excess of billings/(billing in excess of costs) $155,429  $(674,891)

 

For the three months ended December 31, 2025, and 2024, the Company recognized revenue of $1,271,877 and $760,431, respectively, that was previously included in the beginning balance of contract liabilities.

 

20

 

 

The following table summarizes the net activity of the contract assets and contract liabilities for the three months ended December 31, 2025, and 2024.

SUMMARY OF CONTRACT ASSETS AND CONTACT LIABILITIES 

         
  For the three months ended
  December 31,
2025
  December 31,
2024
 
Costs and Estimated Earnings in Excess of Billings on Uncompleted Contracts        
Contract asset, beginning balance $980,164  $985,207 
Changes in revenue billed, contract price or cost estimates  717,527   556,032 
Contract asset, net, ending balance $1,697,691  $1,541,239 
Billings in Excess of Costs and Estimated Earnings on Uncompleted Contracts        
Contract liability, beginning balance  (1,655,055) $(1,254,204)
Changes in revenue billed, contract price or cost estimates  112,793   (24,981)
Contract liability, ending balance $(1,542,262) $(1,279,185)
Net Billings in Excess of Costs and Estimated Earnings on Uncompleted Contracts        
Net billings in excess of costs, beginning balance $(674,891) $(268,997)
Changes in revenue billed, contract price or cost estimates  830,320   531,051 
Net costs in excess of billings, ending balance $155,429  $262,054 

 

NOTE 17 – RELATED PARTY TRANSACTIONS

 

On November 22, 2022, the Company entered into two Asset Purchase Agreements and one Simple Agreement for Future Equity (“SAFE”) with the Company’s CEO, Saagar Govil, to secure the sale of the subsidiaries Cemtrex Advanced Technologies, Inc, which include the brand SmartDesk, and Cemtrex XR, Inc., which include the brands Cemtrex XR, Virtual Driver Interactive, Bravo Strong, and good tech (formerly Cemtrex Labs), to Mr. Govil.

 

On January 6, 2025, the Company and Saagar Govil signed an agreement to revise the purchase price structure and payment terms.

 

The Agreement’s Purchase Price provisions were amended to reflect that the Purchase Price will solely consist of the royalties based on the actual revenues generated in the three years following closing. The provision requiring the total sum of royalties to reach a minimum of $820,000, with any shortfall to be paid by Purchaser, was removed from the Agreement.

 

Additionally, it was agreed that the payment terms due under the royalties shall be as follows commencing on January 1, 2025:

 

First Year (January 2025) Monthly Payment: $10,000
Second Year (January 2026) Monthly Payment: $20,000
Balloon Payment at the end of the Second Year (December 31, 2026): Total outstanding royalties

 

This transaction was approved by the Board of Directors with Saagar Govil abstaining from the vote.

 

Based on the new payment terms, management determined that it was appropriate to remove the previously recognized royalty receivable of $280,545from the financial statements as of December 31, 2024.

 

As of December 31, 2025, there were royalties receivable from the sale of Cemtrex, XR, Inc. of $462,467, of which $240,000 is considered short-term and is presented on the Company’s unaudited Condensed Consolidated Balance Sheet under the caption “Trade receivables, net – related party. The Company has taken a $165,771 allowance for expected credit losses against these royalties.

 

As of December 31, 2025, there was $527,877in trade receivables due from the Cemtrex XR successor company, CXR, Inc. Of these receivables $240,000is the short term due on the royalties on CXR Inc.’s revenues. The remaining $287,877is related to the services provided by Cemtrex Technologies Pvt. Ltd. in the normal course of business.

 

21

 

 

NOTE 18 – EXPECTED CREDIT LOSSES

 

The following table summarized the Company’s activity for expected credit losses for the three months ended December 31, 2025.

SCHEDULE OF CURRENT EXPECTED CREDIT LOSSES 

  Trade receivables, net  Contract assets, net  Royalties receivable, net - related party 
As of September 30, 2025 $152,415  $9,704  $165,771 
Provision  -   1,135   - 
Recovery  (9,691)  -   - 
Write-off  -   -   - 
As of December 31, 2025 $142,724  $10,839  $165,771 

 

NOTE 19 – LEASES

 

The Company is party to contracts where we lease property from others under contracts classified as operating leases. The Company primarily leases office and operating facilities, vehicles, and office equipment. The weighted average remaining term of our operating leases was approximately 2.43 years at December 31, 2025, and 3.30 years at December 31, 2024. The weighted average discount rate used to measure lease liabilities was approximately 6.31% at December 31, 2025, and 6.22% at December 31, 2024. The Company used the rate implicit in the lease, where known, or its incremental borrowing rate as the rate used to discount the future lease payments.

 

The Company has elected not to recognize lease assets and liabilities for leases with a term of 12 months or less.

 

The Company’s security segment leases approximately 350 square feet of office space in Clovis, CA on a month-to-month lease at a rent of $2,075 per month. Short-term rent expense was $6,225 for the three months ended December 31, 2025, and $11,381 for the three months ended December 31, 2024. A reconciliation of undiscounted cash flows to operating lease liabilities recognized in the unaudited condensed consolidated balance sheet at December 31, 2025, is set forth below:

SCHEDULE OF RECONCILIATION OF UNDISCOUNTED CASH FLOWS TO OPERATING LEASE LIABILITIES 

Years ending September 30, Operating Leases 
Remainder of 2026  947,052 
2027  827,058 
2028  474,870 
2029  224,391 
2030  323,710 
Undiscounted lease payments  2,797,081 
Amount representing interest  (623,764)
Discounted lease payments  2,173,317 
Less short-term operating lease liabilities  989,401 
Long-term operating lease liabilities $1,183,916 

 

Lease costs for the three months ended December 31, 2025, and 2024 are set forth below:

SCHEDULE OF LEASE COSTS 

         
  

For the three months ended

 
  December 31, 
  2025  2024 
Operating lease costs:        
Operating lease costs  263,005   256,271 
Short-term lease costs  6,420   14,406 
Total lease cost $269,425  $270,677 

 

NOTE 20 – LINES OF CREDIT AND LONG-TERM LIABILITIES

 

Revolving line of credit

 

On October 5, 2023, the Company obtained a revolving line of credit in the amount of $5,000,000from Pathward, N.A.. The interest rate will be a rate which is equal to three percentage points (3%) in excess of that rate shown in the Wall Street Journal as the prime rate (the “Effective Rate”) and matures twenty-four months24 from the closing date. This loan is secured by the Company’s eligible accounts receivable and eligible finished goods inventory. The Company’s ability to borrow against the line of credit is limited by the value of the eligible assets. As of December 31, 2025, the Company had enough eligible assets to access approximately $2,400,000 of the credit line. The Company was in compliance with all loan covenants as of December 31, 2025. As of December 31, 2025, and September 30, 2025, this loan had a balance of $1,948,258, and $3,176,096, respectively.

 

22

 

 

Notes payable

 

On November 7, 2025, the Company issued a note payable to Streeterville Capital, LLC in the amount of $7,025,000. This note carries interest between November 7, 2025, and December 31, 2025, of SOFR (3.87% as of December 31, 2025), after December 31, 2025, 8%, This Note matures eighteen (18) months from the issuance date with redemptions beginning at six (6) months from the issuance date. After deduction of legal fees of $25,000, the Company received $7,000,000 in cash. Additionally, this note contains an additional interest provision that if this note is outstanding on January 1, 2026, a one-time additional interest fee of $1,050,00 will automatically be added to the outstanding balance. The Company recorded this fee on January 1, 2026.

 

The following table outlines the Company’s secured liabilities:

SCHEDULE OF LINES OF CREDIT AND AND LONG TERM LIABILITIES 

      December 31,  September 30, 
  Interest Rate Maturity 2025  2025 
Fulton Bank - $312,000 fund equipment for AIS. The Company was in compliance with loan covenants as of September 30, 2025. This loan is secured by certain assets of the Company. SOFR plus 2.37% (6.24% as of December 31, 2025 and 6.61% as of September 30, 2025). 9/30/2029  243,500   257,704 
             
Fulton Bank mortgage $2,476,000. The Company was in compliance with loan covenants as of September 30, 2025. This loan is secured by the underlying asset. SOFR plus 2.62% (6.49% on December 31, 2025 and 6.86% on September 30, 2025). 1/28/2040  2,012,447   2,034,048 
             
Fulton Bank (HEISEY) - $1,200,000 mortgage loan; requires monthly principal and interest payments through August 1, 2043 with a final payment of remaining principal on September 1, 2043; The loan is collateralized by 615 Florence Street and 740 Barber Street and guaranteed by AIS and Cemtrex. SOFR plus 2.80% per annum (6.67% as of December 31, 2025 and 7.04% as of September 30, 2025). 9/30/2043  1,138,573   1,146,630 
             
Fulton Bank (HEISEY) - $2,160,000. promissory note related to purchase of Heisey; requires 84 monthly principal and interest payments; The note is collateralized by the Heisey assets and guaranteed by the Parent; matures in 2030. SOFR plus 2.80% per annum (6.67% as of December 31, 2025 and 7.04% as of September 30, 2025). 7/1/2030  1,542,885   1,613,677 
             
Note payable - $9,205,000. Less original issue discount $1,200,000 and legal fees $5,000,net cash received $8,000,000. 28,572 shares of common stock valued at $700,400 recognized as additional original issue discount. Unamortized original issue discount balance of $0 as of September 30, 2025 and September 30, 2024. 8% 2/22/2027  136,773   7,871,777 
             
Note payable - $580,000. Less original issue discount $75,000 and legal fees $5,000,net cash received $500,000. Unamortized original issue discount balance of $33,333 as of September 30, 2025. 8% 5/21/2026  634,615   621,773 
             
Note payable - $7,025,000. Less legal fees $25,000,net cash received $7,000,000. A $1,050,000 additional interest provision was recorded on January 1, 2026 Between November 7, 2025 and December 31, 2025, SOFR (3.87% as of December 31, 2025), after December 31, 2025, 8% 5/6/2027  7,065,875   - 
             
Less: Unamortized original issue discount      (20,833)  (33,333)
Total debt     $12,753,835  $13,512,276 
Less: Current maturities      (4,714,398)  (8,925,497)
Long-term debt     $8,039,437  $4,586,779 

 

NOTE 21 – STOCKHOLDERS’ EQUITY

 

Series 1 Preferred Stock

 

The Company’s Series 1 Preferred Stock is quoted on the OTC Markets OTCID tier under the symbol “CETXP.”

 

During the three months ended December 31, 2025, 135,592 shares of Series 1 Preferred Stock were issued to pay dividends to holders of Series 1 Preferred Stock.

 

As of December 31, 2025, and September 30, 2025, there were 2,840,919 and 2,705,327 shares of Series 1 Preferred Stock issued and 2,776,819and 2,641,227 shares of Series 1 Preferred Stock outstanding, respectively.

 

23

 

 

Common Stock

 

On October 2, 2024, November 26, 2024, and September 29, 2025, the Company completed a 60:1, 35:1, and 15:1 respectively, reverse stock split on its common stock. All share and per share data have been retroactively adjusted for the reverse splits.

 

During the three months ended December 31, 2025, 29,943 shares of common stock were issued for the exercise of 9,981 Series A Warrants under the Alternative Cashless Exercise option as adjusted for exercise price adjustments.

 

During the three months ended December 31, 2025, there were 67,671 shares issued for rounding on September 29, 2025, reverse stock split.

 

During the three months ended December 31, 2025, 2,316,480 shares of common stock were issued for the exercise of 2,316,480 Series B Warrants which generated $5,657,264 in proceeds.

 

During the three months ended December 31, 2025, 3,000,296 shares of the Company’s common stock have been issued to satisfy $7,756,167of notes payable, $87,833 in accrued interest, and $11,798,283 of excess value of shares issued recorded as interest expense. Such shares were issued pursuant to the exemption contained under Section 4(a)(2) of the Securities Act of 1933, as amended.

 

Series A and Series B Warrants

 

The following table summarizes information about shares issuable under warrants outstanding as of December 31, 2025.

SCHEDULE SHARES ISSUABLE UNDER WARRANTS OUTSTANDING 

  

Warrant Shares

Outstanding

  

Weighted Average

Exercise Price

  

Weighted Average

Remaining

Contractual Term (in years)

 
Outstanding at September 30, 2024  49,709,047  $0.23   2.77 
Warrants granted  -         
Warrants exercised  (29,070,304) $0.12     
Warrants forfeited  -         
Warrants cancelled  -         
Exercise price adjustments  (18,971,637)        
Outstanding at September 30, 2025  1,667,106  $4.84   3.37 
Warrants granted  -         
Warrants exercised  (2,346,423) $2.41     
Warrants forfeited  -         
Warrants cancelled  -         
Exercise price adjustments  2,062,572         
Outstanding at December 31, 2025  1,383,255  $1.74   2.77 

 

On October 13, 2025, the Company issued shares of common stock to relieve debt. At the time, the Company had 147,324 Series A Warrants and1,519,782 Series B Warrants outstanding at an exercise price of $5.304. According to the terms of the Series A and Series B warrants, in the event of a issuance below the current exercise price, the exercise price resets to the lower of (i) the public offering price, or (ii) the lowest VWAP during the period commencing five (5) consecutive trading days commencing on the republic offering effective date and the number of warrants are adjusted as to keep the aggregate value of the warrants then outstanding remains unchanged. On October 17, 2025, it was determined that the exercise price has reset to $4.56.

 

The following table illustrates the adjustment.

SCHEDULE OF WARRANTS ADJUSTMENT 

  Warrants outstanding  Aggregate Value  

Adjusted number of

warrants outstanding

 
Series A Warrants  147,324  $260,467   57,120 
Series B Warrants  1,519,782  $8,061,006   1,767,778 

 

24

 

 

On December 11, 2025, the Company closed on a Securities Purchase agreement of common stock. At the time, the Company had 57,120 Series A Warrants and 1,757,778 Series B Warrants outstanding at an exercise price of $4.56. According to the terms of the Series A and Series B warrants, in the event of a public offering, the exercise price resets to the lower of (i) the public offering price, or (ii) the lowest VWAP during the period commencing five (5) consecutive trading days commencing on the republic offering effective date and the number of warrants are adjusted as to keep the aggregate value of the warrants then outstanding remains unchanged. On December 17, 2025, it was determined that the exercise price has reset to $2.433.

 

The following table illustrates the adjustment.

 

  Warrants outstanding  Aggregate Value  

Adjusted number of

warrants outstanding

 
Series A Warrants  57,120  $260,467   107,058 
Series B Warrants  1,757,778  $8,015,406   3,294,469 

 

On December 30, 2025, the Company closed on a Securities Purchase agreement of common stock. At the time, the Company had 78,489 Series A Warrants and 987,987 Series B Warrants outstanding at an exercise price of $2.433. According to the terms of the Series A and Series B warrants, in the event of a public offering, the exercise price resets to the lower of (i) the public offering price, or (ii) the lowest VWAP during the period commencing five (5) consecutive trading days commencing on the republic offering effective date and the number of warrants are adjusted as to keep the aggregate value of the warrants then outstanding remains unchanged. On January 6, 2026, it was determined that the exercise price has reset to $2.25.

 

The following table illustrates the adjustment.

 

  Warrants outstanding  Aggregate Value  

Adjusted number of

warrants outstanding

 
Series A Warrants  78,489  $236,183   104,792 
Series B Warrants  987,987  $2,403,749   1,068,339 

 

For the three months ended December 31, 2025, and 2024 the company recognized a loss on the fair value of the common shares issued for the exercised warrants of $4,674,806 and a loss of $15,796,105, respectively, which represents the difference between the fair value of the shares issued and the value of the warrants exercised.

 

For the three months ended December 31, 2025, and 2024 the company recognized a loss on changes in fair value of warrant liability of $688,671, and $10,020,212, respectively, which represents the change in the fair value of the of the warrants unexercised at the measurement period.

 

December 2025 Equity Offerings

 

On December 11, 2025, the Company entered into a Securities Purchase Agreement with a single accredited institutional investor pursuant to which the Company agreed to issue and sell to the Purchaser, in a registered direct offering securities consisting of shares of the Company’s common stock, par value $0.001 per share, and/or pre-funded warrants to purchase shares of Common Stock at $3.00 per share/warrant for aggregate gross proceeds of $2,000,000. The Offering closed on December 11, 2025. The Company issued 310,000 shares of common stock and prefunded warrants to purchase 356,667 shares of common stock. The Prefunded warrants were immediately exercised, and the Company issued 666,667 shares of common stock in the aggregate.

 

On December 23, 2025, the Company entered into a Securities Purchase Agreement with a single accredited institutional investor pursuant to which the Company agreed to issue and sell to the Purchaser, in a registered direct offering securities consisting of shares of the Company’s common stock, par value $0.001 per share, and/or pre-funded warrants to purchase shares of Common Stock at $2.50per share/warrant for aggregate gross proceeds of $2,000,000. The Offering closed on December 23, 2025. The Company issued 330,000 shares of common stock and prefunded warrants to purchase 470,000 shares of common stock. The Prefunded warrants were immediately exercised, and the Company issued 800,000 shares of common stock in the aggregate.

 

25

 

 

On December 30, 2025, the Company entered into a Securities Purchase Agreement with a single accredited institutional investor pursuant to which the Company agreed to issue and sell to the Purchaser, in a registered direct offering securities consisting of shares of the Company’s common stock, par value $0.001 per share, and/or pre-funded warrants to purchase shares of Common Stock at $2.25 per share/warrant for aggregate gross proceeds of $2,000,000. The Offering closed on December 30, 2025. The Company issued 330,000 shares of common stock and prefunded warrants to purchase 548,889 shares of common stock. The Prefunded warrants were immediately exercised, and the Company issued 888,889 shares of common stock in the aggregate.

 

NOTE 22 – SHARE-BASED COMPENSATION

 

For the three months ended December 31, 2025, and 2024, the Company recognized $0 and $4,087 of share-based compensation expense on its outstanding options, respectively. As of December 31, 2025, there was no unrecognized share-based compensation expense.

 

During the three months ended December 31, 2025, no options were granted, cancelled, or forfeited.

 

NOTE 23 – COMMITMENTS AND CONTINGENCIES

 

From time to time, the Company and its subsidiaries are involved in legal proceedings that are incidental to the operation of our business. The Company continues to defend vigorously against all claims. Although the ultimate outcome of any legal matter cannot be predicted with certainty, based on present information, including assessment of the merits of the particular claim, as well as current accruals and insurance coverage, the Corporation does not expect that such legal proceedings will have a material adverse impact on its unaudited condensed consolidated financial statements.

 

NOTE 24 – INCOME TAXES

 

For the three months ended December 31, 2025, and 2024, the Company recorded an income tax expense of approximately $266,326 and $120,538, respectively. These taxes are related to our international operations and state taxes of certain subsidiaries.

 

As of year-end 2025, the Company had federal, state, and foreign net operating losses (“NOL”) of approximately $68.9 million, $84.0 million, and $9.8 million, respectively. The Company has pre 2018 TCJA NOLs and post 2017 TCJA NOLs. Pre 2018 NOLs will expire in 20 years with the first amount expiring in 2030 and the post 2017 NOLs can be carried forward indefinitely. Generally, state NOLs have different NOL carryforward rules, with some pre-2018 NOLs being able to be carried forward indefinitely. The first amount of state NOLs begin to expire in 2026. In accordance with Section 382 of the U.S. Internal Revenue Code, the usage of the Company’s NOL carryforwards is subject to annual limitations following greater than 50% ownership changes. Tax returns for the years ended 2022 through 2025 are subject to review by tax authorities.

 

The Company’s effective tax rates for the three months ended December 31, 2025, and 2024, were (1.31%) and (0.42%) respectively.

 

NOTE 25 – SUBSEQUENT EVENTS

 

On January 9, 2026, Cemtrex, Inc. (the “Company”) entered into a Securities Purchase Agreement (the “Purchase Agreement”) with a single accredited institutional investor (the “Purchaser”), pursuant to which the Company agreed to issue and sell to the Purchaser, in a registered direct offering (the “Offering”), securities consisting of shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”), and/or pre-funded warrants to purchase shares of Common Stock (the “Pre-Funded Warrants”), for aggregate gross proceeds of $4,000,000. The Offering closed on January 9, 2026. The Company issued 400,000 shares of common stock and prefunded warrants to purchase 1,069,507 shares of common stock, all the prefunded warrants were immediately exercised.

 

On January 8, 2026, the Company completed the acquisition of Invocon. As a result of the transaction, Invocon became a wholly owned subsidiary of the Company. The purchase price of $7,060,000 was paid in cash at closing. Invocon will launch the Company’s Aerospace and Defense segment with reporting results beginning in the second quarter of fiscal year 2026.

 

On February 5, 2026, the Company, through its subsidiary AIS, acquired substantially all the assets of Richland Industries LLC (“Richland”), an industrial services and fabrication company located in Tennessee. In connection with the transaction, AIS established a new subsidiary, AIS as part of the Company’s Industrial Services Segment. The purchase price of $600,000 was paid via a note payable issued by Fulton Bank. This note carries interest of 6.09% and matures on February 1, 2031. In addition, the Company purchased Richland’s primary facility for $4,900,000 via a $3,920,000 mortgage issued by Fulton Bank and the balance including taxes, closing costs, and fees in cash. This mortgage has carries interest of SOFR plus 2.75% and matures on February 1, 2041.

 

On various dates in January 2026, the Company issued 8,030 shares of common stock to satisfy 8,030 Series B Warrants. The exercises raised $18,068 of cash.

 

26

 

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

Except for historical information contained in this report, the matters discussed are forward-looking statements that involve risks and uncertainties. When used in this report, words such as “anticipates”, “believes”, “could”, “estimates”, “expects”, “may”, “plans”, “potential” and “intends” and similar expressions, as they relate to the Company or its management, identify forward-looking statements. Our operations involve risks and uncertainties, many of which are outside our control, and any one of which, or a combination of which, could materially affect our results of operations and whether the forward-looking statements ultimately prove to be correct. We have based these forward-looking statements largely on our current expectations and projections about future events and trends that we believe may affect our financial condition, results of operations, business strategy, short-term and long-term business operations and objectives, and financial needs. Such forward-looking statements are based on the beliefs of the Company’s management, as well as assumptions made by and information currently available to the Company’s management. Among the factors that could cause actual results to differ materially are the following: the effect of business and economic conditions; the impact of competitive products and their pricing; unexpected manufacturing or supplier problems; the Company’s ability to maintain sufficient credit arrangements; changes in governmental standards by which our environmental control products are evaluated and the risk factors reported from time to time in the Company’s SEC reports, including its recent report on Form 10-K. The Company undertakes no obligation to update forward-looking statements as a result of future events or developments.

 

General Overview

 

Cemtrex was incorporated in 1998 in the state of Delaware and has evolved through strategic acquisitions and internal growth into a leading multi-industry company. Unless the context requires otherwise, all references to “we”, “our”, “us”, “Company”, “registrant”, “Cemtrex” or “management” refer to Cemtrex, Inc. and its subsidiaries.

 

The Company’s reporting segments consist of Security and Industrial Services. Additionally, the Company’s operational structure also reports unallocated corporate expenses.

 

Security

 

Cemtrex’s Security segment operates under the brand of its majority owned subsidiary, Vicon Industries, Inc. (“Vicon”), which provides end-to-end security solutions to meet the toughest corporate, industrial, and governmental security challenges. Vicon’s products include browser-based video monitoring systems and analytics-based recognition systems, cameras, servers, and access control systems for every aspect of security and surveillance in industrial and commercial facilities, federal prisons, hospitals, universities, schools, and federal and state government offices. Vicon provides innovative, mission critical security and video surveillance solutions utilizing Artificial Intelligence (AI) based data algorithms.

 

Industrial Services

 

Cemtrex’s Industrial Services segment operates under the brand, Advanced Industrial Services (“AIS”), which offers single-source expertise and services for rigging, millwrighting, in plant maintenance, equipment erection, relocation, and disassembly to diversified customers. AIS installs high precision equipment in a wide variety of industrial markets like automotive, printing & graphics, industrial automation, packaging, and chemicals, among others. AIS is a leading provider of reliability-driven maintenance and contracting solutions for machinery, packaging, printing, chemical, and other manufacturing markets. The focus is on customers seeking to achieve greater asset utilization and reliability to cut costs and increase production from existing assets, including small projects, sustaining capital, turnarounds, maintenance, specialty welding services, and high-quality scaffolding.

 

Significant Accounting Policies and Estimates

 

Our discussion and analysis of our financial condition and results of operations are based upon the accompanying unaudited condensed consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”). The preparation of financial statements in conformity with U.S. GAAP requires management to make judgments, estimates and assumptions that affect the reported amounts of assets, liabilities, revenue, expenses, and the related disclosures at the date of the financial statements and during the reporting period. Although these estimates are based on our knowledge of current events, our actual amounts and results could differ from those estimates. The estimates made are based on historical factors, current circumstances, and the experience and judgment of our management, who continually evaluate the judgments, estimates and assumptions and may employ outside experts to assist in the evaluations.

 

27

 

 

Certain of our accounting policies are deemed “significant”, as they are both most important to the financial statement presentation and require management’s most difficult, subjective, or complex judgments as a result of the need to make estimates about the effect of matters that are inherently uncertain. For a discussion of our significant accounting policies, see “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our Annual Report on Form 10-K for the year ended September 30, 2025.

 

Results of Operations – For the three months ended December 31, 2025, and 2024

 

Revenues

 

Our Security segment revenues for the three months ended December 31, 2025, increased by $57,829 or 1% to $5,511,528 from $5,453,699 for the three months ended December 31, 2024. This increase is mainly due to increased demand for the Company’s products.

 

Our Industrial Services segment revenues for the three months ended December 31, 2025, increased by $2,324,956 or 28%, to $10,611,156 from $8,286,200, for the three months ended December 31, 2024. This increase is mainly due to increased demand for the segment’s services.

 

There was unallocated revenue under the Corporate segment of $10,627 for the three months ended December 31, 2025. This revenue is related to the Company’s investment in digital assets.

 

Gross Profit

 

Gross Profit for the three months ended December 31, 2025, was $5,621,866 or 35% of revenues as compared to gross profit of $5,701,936 or 41% of revenues for the three months ended December 31, 2024.

 

Gross profit in our Security segment was $2,160,678 or 39% of the segment’s revenues for the three months ended December 31, 2025, as compared to gross profit of $2,839,759 or 52% of the segment’s revenues for the period ended December 31, 2024. Gross profit in our security segment have been impacted by tariffs.

 

Gross profit in our Industrial Services segment was $3,450,471 or 33% of the segment’s revenues for the three months ended December 31, 2025, as compared to gross profit of $2,862,177 or 35% of the segment’s revenues for the period ended December 31, 2024. Gross profit as a percentage of revenues decreased due to lower margins on projects in the three months ended December 31, 2025, compared to the three months ended December 31, 2024.

 

General and Administrative Expenses

 

General and administrative expenses for the three months ended December 31, 2025, increased $833,302 or 12% to $7,926,591 from $7,093,289 for the three months ended December 31, 2024. The increase in general and administrative expenses is mainly related to a one-time write off of obsolete demonstration equipment of $441,624, increased legal expenses related to the preliminary work on acquisitions, depreciation on recently acquired fixed assets, and travel related to trade show attendance.

 

Research and Development Expenses

 

Research and Development expenses for the three months ended December 31, 2025, were $501,435 compared to $890,083 for the three months ended December 31, 2024, a decrease of $388,648 or 44%. Research and Development expenses are related to the Security Segment’s development of next generation solutions associated with security and surveillance systems software.

 

28

 

 

Other Income/Expense

 

Other expense for the three months ended December 31, 2025, was $17,515,652, as compared to expense of $26,265,257 for the three months ended December 31, 2024. Other expense for the three months ended December 31, 2025, was mainly driven by interest expense of $12,123,695 of which $11,798,283 represents the discount on shares issued to settle debt. Other expense for the three months ended December 31, 2024, was mainly driven by a loss on excess fair value of the warrants at exercise of $15,796,105.

 

Provision for Income Taxes

 

During the three months ended December 31, 2025, and 2024, the Company had income tax expense from continuing operations of $266,326 and $120,538, respectively. The provision for income tax is estimated based upon the current income projections of the Company, the effective rate of the prior year, and the Company’s current ability to utilize net loss carryforwards. The Company’s effective tax rate for the three months ended December 31, 2025, and 2024, was (1.31%) and (0.42%) respectively.

 

Effects of Inflation

 

The Company’s business and operations have been affected by inflation during the periods for which financial information is presented. In response, the Company has instituted price increases and initiated cost-saving measures to mitigate the effects of inflation on operations.

 

Liquidity and Capital Resources

 

Working capital was $24,748,544 at December 31, 2025, compared to working capital of $5,184,339 at September 30, 2025. This includes cash and cash equivalents and restricted cash of $21,782,533 at December 31, 2025, and $6,347,041 at September 30, 2025. The increase in working capital was primarily due to cash raised in the equity offerings and Series B Warrant exercises and the payment of the Company’s debt through equity.

 

Cash used by operating activities for the three months ended December 31, 2025, was $891,914 and $1,201,817 for the three months ended December 31, 2024. Our operating cash flow was mainly the result of our net loss, less the non-cash adjustments, combined with operating changes in inventory, contract assets, and accrued expenses.

 

Trade receivables decreased by $3,431,109 or 26% to $9,702,315 at December 31, 2025, from $13,133,424 at September 30, 2025. The decrease in trade receivables is attributable to a decrease in sales as compared to the fourth quarter of fiscal year2025.

 

Cash used by investing activities for the three months ended December 31, 2025, was $253,061 compared to $1,008,899 for the three months ended December 31, 2024. Investing activities for the three months ended December 31, 2025, were driven by the Company’s purchase of property and equipment and investment in marketable securities. Investing activities for the three months ended December 31, 2024, were driven by the Company’s purchase of property and equipment and investment in Masterpiece VR.

 

Cash provided by financing activities for the three months ended December 31, 2025, was $17,305,299 compared to $2,387,449 for the three months ended December 31, 2024. Financing activities for the three months ended December 31, 2025, were primarily driven by the proceeds from equity offerings, proceeds of a note payable, and proceeds from the exercise of the Company’s Series B Warrants. Financing activities for the three months ended December 31, 2024, were primarily driven by the proceeds from the Company’s revolving line of credit, notes payable, and proceeds from the exercise of the Company’s Series B Warrants.

 

29

 

 

The Company’s working capital may not be sufficient to cover operating costs which indicates substantial doubt regarding the Company’s ability to continue as a going concern, the Company has historically, from time to time, satisfied and may continue to satisfy certain short-term liabilities through the issuance of common stock, thus reducing our cash requirement to meet our operating needs. The Company has $21,782,533 in cash and cash equivalents and restricted cash as of December 31, 2025. Additionally, the Company has (i) secured a line of credit for its Vicon brand to fund operations, which as of December 31, 2025, has available capacity of approximately $420,000, (ii) continually reevaluate our pricing model on our Vicon brand to improve margins on those products, (iii) raised $5,657,264 through the exercise of our Series B warrants during the quarter ended December 31, 2025 (iv) raised $6,000,000 in gross proceeds in equity offering during the quarter ended December 31, 2025, and an additional $4,000,000 in gross proceeds subsequent to December 31, 2025.

 

In the event additional capital is raised through equity offerings and/or debt is satisfied with equity, it may have a dilutive effect on our existing stockholders. While the Company believes these plans, if successful, would be sufficient to meet the capital demands of our current operations for at least the next twelve months, there is no guarantee that we will succeed. Overall, there is no guarantee that cash flow from our existing or future operations and any external capital that we may be able to raise will be sufficient to meet our working capital needs. The Company currently does not have adequate cash or available liquidity/available capacity on our lines of credit to meet our short or long-term needs. Absent an ability to raise additional outside capital and restructure or refinance all or a portion of our debt, the Company will be unable to meet its obligations as they become due over the next twelve months beyond the issuance date.

 

Each segment of the Company’s operations has positioned itself for growth and the Company’s long-term objectives include increasing marketing and sales for the Company’s products and services in each segment, increasing the Company’s presence through collaboration partnerships in each segment and through strategic acquisitions of complementary businesses for each segment. These long-term objectives will require sufficient cash to complete, and the Company expects to fund these objectives with cash on hand, issuance of debt, and from proceeds from the sale of the Company’s securities, which may not be sufficient to fully implement our growth initiatives.

 

The unaudited condensed consolidated financial statements do not include any adjustments relating to this uncertainty.

 

30

 

 

Item 4. Controls and Procedures

 

Evaluation of Disclosure Controls and Procedures

 

Disclosure controls and procedures reporting as promulgated under the Exchange Act is defined as controls and procedures that are designed to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act are recorded, processed, summarized and reported within the time periods specified in the SEC rules and forms. Disclosure controls and procedures include without limitation, controls and procedures designed to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is accumulated and communicated to our management, including our Chief Executive Officer (“CEO”) and Chief Financial Officer (“CFO”), or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.

 

Our CEO and our CFO have evaluated the effectiveness of the design and operation of our disclosure controls and procedures as of December 31, 2025. Based on their evaluation, our management has concluded that as of December 31, 2025, our disclosure controls and procedures were effective.

 

Changes in Internal Control Over Financial Reporting

 

There have been no changes in our internal control over financial reporting (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended) that occurred during the three months ended December 31, 2025, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

Limitations on the Effectiveness of Controls

 

Our management, including our CEO and CFO, does not expect that our disclosure controls and procedures or our internal controls will prevent all errors and all fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Due to the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within our company have been detected.

 

31

 

 

Part II Other Information

 

Item 1. Legal Proceedings.

 

To the Company’s knowledge, there is no action, suit, proceeding, inquiry or investigation before or by any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge of the executive officers of our Company or any of our subsidiaries, threatened against or affecting our Company, our common stock, any of our subsidiaries or of our Company’s or our Company’s subsidiaries’ officers or directors in their capacities as such, in which an adverse decision could have a material adverse effect.

 

Item 1A. Risk Factors

 

Our business faces many risks, a number of which are described in the section captioned “Risk Factors” in our Annual Report for the year ended September 30, 2025, filed with the SEC on December 29, 2025 and amended on January 16, 2026. The risks described may not be the only risks we face. Other risks of which we are not yet aware, or that we currently believe are not material, may also materially and adversely impact our business operations or financial results. If any of the events or circumstances described in the risk factors contained in our Annual Report or Quarterly Report occur, our business, financial condition or results of operations could be adversely impacted and the value of an investment in our securities could decline. Investors and prospective investors should consider the risks described in our Annual Report and Quarterly Reports, and the information contained in the section captioned “Forward-Looking Statements” and elsewhere in this Quarterly Report before deciding whether to invest in our securities.

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

 

Preferred Stock

 

During the three months ended December 31, 2025, 135,592 shares of Series 1 Preferred Stock were issued to pay dividends to holders of Series 1 Preferred Stock.

 

Common Stock

 

During the three months ended December 31, 2025, 3,000,296 shares of the Company’s common stock have been issued to satisfy $7,756,167 of notes payable, $87,833 in accrued interest, and $11,798,283 of excess value of shares issued recorded as interest expense. Such shares were issued pursuant to the exemption contained under Section 4(a)(2) of the Securities Act of 1933, as amended.

 

Item 3. Defaults Upon Senior Securities

 

None.

 

Item 4. Mine Safety Disclosures

 

N/A

 

Item 5. Other Information

 

None.

 

32

 

 

Item 6. Exhibits

 

Exhibit   Incorporated by Reference Filed or Furnished 
Number Exhibit Description Form Filing Date Herewith
2.1 Stock Purchase Agreement, dated December 15, 2015 Form 8-K/A 9/26/2016  
3.1 Certificate of Incorporation filed with the State of Delaware. Form 10-12G  5/22/2008  
3.2 Bylaws Form 10-12G  5/22/2008  
3.3 Amendment to Certificate of Incorporation Form 10-12G  5/22/2008  
3.4 Amendment to Certificate of Incorporation Form 10-12G  5/22/2008  
3.5 Amendment to Certificate of Incorporation Form 10-12G  5/22/2008  
3.6 Amendment to Certificate of Incorporation Form 10-12G  5/22/2008  
3.7 Amendment to Certificate of Incorporation Form 8-K 8/22/2016  
3.8 Amendment to Certificate of Incorporation Form 8-K 9/30/2024  
3.9 Amendment to Certificate of Incorporation Form 8-K 11/21/2024  
3.10 Amendment to Certificate of Incorporation Form 8-K 9/24/2025  
3.11 Certificate of Designation of the Series A Preferred Shares Form 8-K 9/10/2009  
3.12 Certificate of Designation of the Series 1 Preferred Shares Form 8-K 1/24/2017  
3.13 Amendment to Certificate of Incorporation Form 8-K 9/8/2017  
3.14 Certificate of Correction to the Certificate of Amendment Form 8-K 6/12/2019  
3.15 Amended Certificate of Designation of the Series 1 Preferred Shares Form 8-K 4/1/2020  
3.16 Amendment to Certificate of Incorporation Form 10-K 1/5/2021  
3.17 Certificate of Correction to the Certificate of Amendment Form 10-Q 5/28/2021  
3.18 Amendment to Certificate of Incorporation Form 8-K 1/20/2023  
3.19 Amendment to Certificate of Incorporation Form 8-K 8/2/2024  
4.1 Form of Subscription Rights Certificate  Form S-1 8/29/2016  
4.2 Form of Series 1 Preferred Stock Certificate Form S-1/A 11/23/2016  
4.3 Form of Series 1 Warrant Form S-1/A 12/7/2016  
4.4 Form of Common Stock Purchase Warrant Form 8-K 3/22/2019  
4.5 Form of Prefunded Warrant Form 8-K 5/3/2024  
4.6 Form of Series A Common Stock Purchase Warrant Form 8-K 5/3/2024  
4.7 Form of Series B Common Stock Purchase Warrant Form 8-K 5/3/2024  
5.1 Opinion of the Doney Law Firm Form S-1/A 4/30/2024  
10.1 Amendment to Loan Documents Between Advanced Industrial Services, Inc. and Fulton Bank, N.A. Form 10-Q 5/11/2023  
10.2 Asset Purchase agreement between Cemtrex, Inc. and Saagar Govil, dated November 22, 2022  Form 8-K 11/29/2022  
10.3 Asset Purchase agreement between Cemtrex, Inc. and Saagar Govil, dated November 22, 2022 Form 8-K 11/29/2022  
10.4 Simple Agreement for Future Equity (SAFE) between Cemtrex, Inc. and Saagar Govil, dated November 18, 2022 Form 8-K 11/29/2022  
10.5 2020 Equity Compensation Plan Form S-8 8/17/2020  
10.6 Asset Purchase Agreement, dated as of June 7, 2023 Form 8-K 12/6/2023  
10.7 Form of Lock-Up Agreement Form S-1/A 4/30/2024  
10.8 Note Purchase Agreement between Cemtrex Inc. and Streeterville Capital, LLC, dated September 30, 2021 Form S-1/A 4/30/2024  
10.9 Amendment to Promissory Note between Cemtrex Inc. and Streeterville Capital, LLC, dated September 14, 2022 Form S-1/A 4/30/2024  
10.10 Amendment to Promissory Note between Cemtrex Inc. and Streeterville Capital, LLC, dated August 30, 2023 Form S-1/A 4/30/2024  
10.11 Form of Underwriting Agreement Form 8-K 5/3/2024  
10.12 Standstill Agreement, dated April 30, 2024 Form 8-K 5/1/2024  
10.13 Underwriting Agreement, dated May 28, 2025 with Aegis Capital Corp. Form 8-K 5/29/2025  
10.14 Share Purchase Agreement between Cemtrex, Inc, Karl F. Kiefer, and Invocon, Inc. Form 8-K 11/19/2025  
10.15 Securities Purchase Agreement, dated December 11, 2025 Form 8-K 12/11/2025  
10.16 Securities Purchase Agreement, dated December 23, 2025 Form 8-K 12/23/2025  
10.17 Securities Purchase Agreement, dated January 9, 2026 Form 8-K 1/9/2026  
21.1 Subsidiaries of the Registrant  Form 10-K 12/29/2025  
31.1 Certification of Chief Executive Officer as required by Rule 13a-14 or 15d-14 of the Exchange Act, as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.     X
31.2 Certification of Interim Chief Financial Officer and Principal Financial Officer as required by Rule 13a-14 or 15d-14 of the Exchange Act, as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.     X
32.1 Certification of Chief Executive Officer Pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act 0f of 2002.     X
32.2 Certification of Interim Chief Financial Officer and Principal Financial Officer Pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act 0f of 2002.     X
97.1 Clawback Policy Form 10-K/A 1/16/2026  
99.1 Order pursuant to Section 8A of the Securities Act – dated September 30, 2022. Form 8-K 10/4/2022  
101.INS Inline XBRL Instance Document     X
101.SCH Inline XBRL Taxonomy Extension Schema     X
101.CAL Inline XBRL Taxonomy Extension Calculation Linkbase     X
101.DEF Inline XBRL Taxonomy Extension Definition Linkbase     X
101.LAB Inline XBRL Taxonomy Extension Label Linkbase     X
101.PRE Inline XBRL Taxonomy Extension Presentation Linkbase     X
104 Cover Page Interactive Data File (embedded within the Inline XBRL document)     X

 

33

 

 

Signatures

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 Cemtrex, Inc.
   
Dated: February 17, 2026 By:/s/Saagar Govil
  Saagar Govil
  Chairman of the Board, CEO,
  President and Secretary (Principal Executive Officer)

 

Dated: February 17, 2026 /s/Paul J. Wyckoff
 Paul J. Wyckoff
 Chief Financial Officer
  and Principal Financial Officer

 

34